CA2846663A1 - Antibacterial compounds and methods for use - Google Patents
Antibacterial compounds and methods for use Download PDFInfo
- Publication number
- CA2846663A1 CA2846663A1 CA2846663A CA2846663A CA2846663A1 CA 2846663 A1 CA2846663 A1 CA 2846663A1 CA 2846663 A CA2846663 A CA 2846663A CA 2846663 A CA2846663 A CA 2846663A CA 2846663 A1 CA2846663 A1 CA 2846663A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- oxo
- dihydropyridine
- carboxylic acid
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 408
- 238000000034 method Methods 0.000 title claims abstract description 282
- 230000000844 anti-bacterial effect Effects 0.000 title description 15
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 56
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 50
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 18
- -1 carboxy, amino Chemical group 0.000 claims description 667
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 251
- 125000003118 aryl group Chemical group 0.000 claims description 133
- 125000000623 heterocyclic group Chemical group 0.000 claims description 96
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 95
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 93
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 70
- 125000001072 heteroaryl group Chemical group 0.000 claims description 63
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 63
- 125000001424 substituent group Chemical group 0.000 claims description 49
- 125000000217 alkyl group Chemical group 0.000 claims description 48
- 150000003839 salts Chemical class 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 31
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 23
- 239000012453 solvate Substances 0.000 claims description 23
- 229910052736 halogen Inorganic materials 0.000 claims description 21
- 239000003242 anti bacterial agent Substances 0.000 claims description 20
- 150000002367 halogens Chemical group 0.000 claims description 20
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 19
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
- 125000004076 pyridyl group Chemical group 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 15
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 15
- 125000001769 aryl amino group Chemical group 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 13
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 12
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 12
- 125000003386 piperidinyl group Chemical group 0.000 claims description 12
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims description 11
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 claims description 11
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims description 11
- 125000003282 alkyl amino group Chemical group 0.000 claims description 11
- 125000002393 azetidinyl group Chemical group 0.000 claims description 11
- 125000002619 bicyclic group Chemical group 0.000 claims description 11
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 11
- 125000002757 morpholinyl group Chemical group 0.000 claims description 11
- 125000004193 piperazinyl group Chemical group 0.000 claims description 11
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 11
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 11
- 241000588724 Escherichia coli Species 0.000 claims description 10
- 241000192125 Firmicutes Species 0.000 claims description 10
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 claims description 10
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 10
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 9
- 229940023064 escherichia coli Drugs 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims description 8
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 8
- 241000425347 Phyla <beetle> Species 0.000 claims description 8
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims description 8
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 claims description 8
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 7
- 239000012458 free base Substances 0.000 claims description 7
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 7
- 125000004043 oxo group Chemical group O=* 0.000 claims description 7
- 125000005983 2,5-diazabicyclo[2.2.1]heptan-2-yl group Chemical group 0.000 claims description 6
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 6
- 241000194032 Enterococcus faecalis Species 0.000 claims description 6
- 241000191967 Staphylococcus aureus Species 0.000 claims description 6
- 229960003405 ciprofloxacin Drugs 0.000 claims description 6
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 6
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000006598 aminocarbonylamino group Chemical group 0.000 claims description 5
- FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 claims description 5
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 241000588626 Acinetobacter baumannii Species 0.000 claims description 4
- 241001156739 Actinobacteria <phylum> Species 0.000 claims description 4
- 241000193738 Bacillus anthracis Species 0.000 claims description 4
- 241001185363 Chlamydiae Species 0.000 claims description 4
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 4
- 241000192142 Proteobacteria Species 0.000 claims description 4
- 241001180364 Spirochaetes Species 0.000 claims description 4
- 229940065181 bacillus anthracis Drugs 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 238000002648 combination therapy Methods 0.000 claims description 4
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 229940045505 klebsiella pneumoniae Drugs 0.000 claims description 4
- 229960003702 moxifloxacin Drugs 0.000 claims description 4
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 241000194031 Enterococcus faecium Species 0.000 claims description 3
- 241000589602 Francisella tularensis Species 0.000 claims description 3
- 241000606768 Haemophilus influenzae Species 0.000 claims description 3
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims description 3
- 241000588655 Moraxella catarrhalis Species 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 3
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 229940118764 francisella tularensis Drugs 0.000 claims description 3
- 229940047650 haemophilus influenzae Drugs 0.000 claims description 3
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 claims description 3
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims description 3
- 125000001041 indolyl group Chemical group 0.000 claims description 3
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims description 3
- 229960003376 levofloxacin Drugs 0.000 claims description 3
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 3
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 3
- 125000006625 (C3-C8) cycloalkyloxy group Chemical group 0.000 claims description 2
- 125000001607 1,2,3-triazol-1-yl group Chemical group [*]N1N=NC([H])=C1[H] 0.000 claims description 2
- 125000005955 1H-indazolyl group Chemical group 0.000 claims description 2
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 claims description 2
- 241000580482 Acidobacteria Species 0.000 claims description 2
- 241001142141 Aquificae <phylum> Species 0.000 claims description 2
- 241000605059 Bacteroidetes Species 0.000 claims description 2
- 241000949049 Caldiserica Species 0.000 claims description 2
- 241000191368 Chlorobi Species 0.000 claims description 2
- 241001142109 Chloroflexi Species 0.000 claims description 2
- 241001143290 Chrysiogenetes <phylum> Species 0.000 claims description 2
- 241000192700 Cyanobacteria Species 0.000 claims description 2
- 241001143296 Deferribacteres <phylum> Species 0.000 claims description 2
- 241000192095 Deinococcus-Thermus Species 0.000 claims description 2
- 241000970811 Dictyoglomi Species 0.000 claims description 2
- 241001260322 Elusimicrobia <phylum> Species 0.000 claims description 2
- 241000588914 Enterobacter Species 0.000 claims description 2
- 241000923108 Fibrobacteres Species 0.000 claims description 2
- 241001453172 Fusobacteria Species 0.000 claims description 2
- 241001265526 Gemmatimonadetes <phylum> Species 0.000 claims description 2
- 241001387859 Lentisphaerae Species 0.000 claims description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 2
- 241000588653 Neisseria Species 0.000 claims description 2
- 241000192121 Nitrospira <genus> Species 0.000 claims description 2
- 241001180199 Planctomycetes Species 0.000 claims description 2
- 241000607768 Shigella Species 0.000 claims description 2
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 2
- 241000390529 Synergistetes Species 0.000 claims description 2
- 241000131694 Tenericutes Species 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 241001143138 Thermodesulfobacteria <phylum> Species 0.000 claims description 2
- 241001141092 Thermomicrobia Species 0.000 claims description 2
- 241001143310 Thermotogae <phylum> Species 0.000 claims description 2
- 241001261005 Verrucomicrobia Species 0.000 claims description 2
- 229960003907 linezolid Drugs 0.000 claims description 2
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 claims description 2
- 229960003085 meticillin Drugs 0.000 claims description 2
- 229960000210 nalidixic acid Drugs 0.000 claims description 2
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims description 2
- 229960004089 tigecycline Drugs 0.000 claims description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 107
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 2
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 claims 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 claims 2
- 229960001225 rifampicin Drugs 0.000 claims 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims 2
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3s)-3,6-diamino-n-[[(2s,5s,8e,11s,15s)-15-amino-11-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3s)-3,6-diamino-n-[[(2s,5s,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 claims 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 claims 1
- SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4s,4as,5ar,12ar)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O SOVUOXKZCCAWOJ-HJYUBDRYSA-N 0.000 claims 1
- WDLWHQDACQUCJR-ZAMMOSSLSA-N (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)/C=C/C)C(O)=O)=CC=C(O)C=C1 WDLWHQDACQUCJR-ZAMMOSSLSA-N 0.000 claims 1
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 claims 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 claims 1
- KTCNGKASVZVXHT-UHFFFAOYSA-N 1,2-dihydropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CNC1 KTCNGKASVZVXHT-UHFFFAOYSA-N 0.000 claims 1
- FQDFQKZAUOUNCX-UHFFFAOYSA-N 4-amino-5-ethyl-6-[1-methyl-2-(piperidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound NC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCCC4)N(C)C3=CC=2)=C1CC FQDFQKZAUOUNCX-UHFFFAOYSA-N 0.000 claims 1
- SATRPQGGTSUTTN-UHFFFAOYSA-N 4-amino-5-ethyl-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound NC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=CC=2)=C1CC SATRPQGGTSUTTN-UHFFFAOYSA-N 0.000 claims 1
- IPKCJQVTRFILHT-UHFFFAOYSA-N 4-amino-6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound NC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=CC=2)=C1CC IPKCJQVTRFILHT-UHFFFAOYSA-N 0.000 claims 1
- FIVCBTRDINJPOE-UHFFFAOYSA-N 4-amino-6-[2-[[3-(dimethylamino)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound NC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)N(C)C)N(C)C3=CC=2)=C1CC FIVCBTRDINJPOE-UHFFFAOYSA-N 0.000 claims 1
- FTGXXRUPIMDVJD-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-(methylaminomethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C FTGXXRUPIMDVJD-UHFFFAOYSA-N 0.000 claims 1
- WXVISNMNNXAHQL-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-(propylaminomethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C WXVISNMNNXAHQL-UHFFFAOYSA-N 0.000 claims 1
- FNFLQJZGEBXICH-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=CC=2)=C1C FNFLQJZGEBXICH-UHFFFAOYSA-N 0.000 claims 1
- SCNGQLHCLOXMTD-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-[(2-methylpropylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCC(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C SCNGQLHCLOXMTD-UHFFFAOYSA-N 0.000 claims 1
- QUQNGMHROUXRSE-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-[(propan-2-ylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNC(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C QUQNGMHROUXRSE-UHFFFAOYSA-N 0.000 claims 1
- HATXFGAJOZUHQS-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-[[(1-methylcyclopropyl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4(C)CC4)N(C)C3=CC=2)=C1C HATXFGAJOZUHQS-UHFFFAOYSA-N 0.000 claims 1
- NMWMFAPJNQFETL-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[1-methyl-2-[[2-(methylamino)ethylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCNC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C NMWMFAPJNQFETL-UHFFFAOYSA-N 0.000 claims 1
- YRWJBALESWCGOH-UHFFFAOYSA-N 4-hydroxy-5-methyl-6-[2-(methylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=C2N3CC(NC)CC3=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C YRWJBALESWCGOH-UHFFFAOYSA-N 0.000 claims 1
- BTANIZOGABTGIT-UHFFFAOYSA-N 4-hydroxy-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C=3NC(=O)C(C(O)=O)=C(O)C=3)=CC=C2N(C)C=1CN1CCCC1 BTANIZOGABTGIT-UHFFFAOYSA-N 0.000 claims 1
- BYYCMAWRMANRBZ-UHFFFAOYSA-N 4-hydroxy-6-[2-[(1-hydroxypropan-2-ylamino)methyl]-1-methylindol-5-yl]-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNC(CO)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C BYYCMAWRMANRBZ-UHFFFAOYSA-N 0.000 claims 1
- JTXPUBUZMHWGDQ-UHFFFAOYSA-N 4-hydroxy-6-[2-[(1-methoxypropan-2-ylamino)methyl]-1-methylindol-5-yl]-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNC(C)COC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C JTXPUBUZMHWGDQ-UHFFFAOYSA-N 0.000 claims 1
- JXNQVMYQHQMVGX-UHFFFAOYSA-N 4-hydroxy-6-[2-[(2-hydroxyethylamino)methyl]-1-methylindol-5-yl]-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCO)N(C)C3=CC=2)=C1C JXNQVMYQHQMVGX-UHFFFAOYSA-N 0.000 claims 1
- UBZFXIJEEZBMGO-UHFFFAOYSA-N 4-hydroxy-6-[2-[(2-methoxyethylamino)methyl]-1-methylindol-5-yl]-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCOC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C UBZFXIJEEZBMGO-UHFFFAOYSA-N 0.000 claims 1
- RHJLYVURYCGACM-UHFFFAOYSA-N 5-(4-fluorophenyl)-4-hydroxy-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C=3C=CC(F)=CC=3)=CC=C2N(C)C=1CN1CCCC1 RHJLYVURYCGACM-UHFFFAOYSA-N 0.000 claims 1
- RBNAHFFWGQCLNT-UHFFFAOYSA-N 5-cyclopropyl-4-hydroxy-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C3CC3)=CC=C2N(C)C=1CN1CCCC1 RBNAHFFWGQCLNT-UHFFFAOYSA-N 0.000 claims 1
- OUKZYCNCWPXGSI-UHFFFAOYSA-N 5-cyclopropyl-6-[2-[(cyclopropylmethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C3CC3)=CC=C2N(C)C=1CNCC1CC1 OUKZYCNCWPXGSI-UHFFFAOYSA-N 0.000 claims 1
- DXYYDYSKZKOKMB-UHFFFAOYSA-N 5-cyclopropyl-6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C1CC1 DXYYDYSKZKOKMB-UHFFFAOYSA-N 0.000 claims 1
- JABFIMDLCCNBTE-UHFFFAOYSA-N 5-ethyl-2-oxo-6-(3-piperidin-1-yl-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl)-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4C(N5CCCCC5)CCN4C3=CC=2)=C1CC JABFIMDLCCNBTE-UHFFFAOYSA-N 0.000 claims 1
- RDJGLYWHBFOAOD-UHFFFAOYSA-N 5-ethyl-2-oxo-6-(3-pyrrolidin-1-yl-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl)-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4C(N5CCCC5)CCN4C3=CC=2)=C1CC RDJGLYWHBFOAOD-UHFFFAOYSA-N 0.000 claims 1
- ZWKFHHKWLLJPAH-UHFFFAOYSA-N 5-ethyl-2-oxo-6-[2-(piperidin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(=O)NC(C2=CN3C=C(CN4CCCCC4)N=C3C=C2)=C1CC ZWKFHHKWLLJPAH-UHFFFAOYSA-N 0.000 claims 1
- UVPZLKUCGQCIEJ-UHFFFAOYSA-N 5-ethyl-2-oxo-6-[2-(pyrrolidin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(=O)NC(C2=CN3C=C(CN4CCCC4)N=C3C=C2)=C1CC UVPZLKUCGQCIEJ-UHFFFAOYSA-N 0.000 claims 1
- QEQPWJGMKDRPTF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-(1-phenylindol-5-yl)-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C3=CC=2)C=2C=CC=CC=2)=C1CC QEQPWJGMKDRPTF-UHFFFAOYSA-N 0.000 claims 1
- QCEPOEQDZQQZOX-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-(2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indol-7-yl)-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC=4CCNCC=4C3=CC=2)=C1CC QCEPOEQDZQQZOX-UHFFFAOYSA-N 0.000 claims 1
- CPQNNOBVQXDKPH-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-(2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-7-yl)-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC=4CNCCC=4C3=CC=2)=C1CC CPQNNOBVQXDKPH-UHFFFAOYSA-N 0.000 claims 1
- OABGFPOPKDCDKU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-(2-propan-2-yl-1,3,4,9-tetrahydropyrido[3,4-b]indol-7-yl)-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC=4CN(CCC=4C3=CC=2)C(C)C)=C1CC OABGFPOPKDCDKU-UHFFFAOYSA-N 0.000 claims 1
- RKAOURQVIDODNF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-(2-propyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-7-yl)-1h-pyridine-3-carboxylic acid Chemical compound C1N(CCC)CCC(C2=CC=3)=C1NC2=CC=3C=1NC(=O)C(C(O)=O)=C(O)C=1CC RKAOURQVIDODNF-UHFFFAOYSA-N 0.000 claims 1
- CHJVYKRZLPQBKD-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-[1-(3-pyrrolidin-1-ylphenyl)indol-5-yl]-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C3=CC=2)C=2C=C(C=CC=2)N2CCCC2)=C1CC CHJVYKRZLPQBKD-UHFFFAOYSA-N 0.000 claims 1
- IPWFFFYICXHPGN-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-[1-(4-pyrrolidin-1-ylphenyl)indol-5-yl]-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C3=CC=2)C=2C=CC(=CC=2)N2CCCC2)=C1CC IPWFFFYICXHPGN-UHFFFAOYSA-N 0.000 claims 1
- QVYDHVXYYGOKAE-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-[1-[4-(trifluoromethyl)phenyl]indol-5-yl]-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C3=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1CC QVYDHVXYYGOKAE-UHFFFAOYSA-N 0.000 claims 1
- AWUMODSCMDIQNR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-2-oxo-6-[2-[4-(trifluoromethyl)phenyl]-1h-indol-5-yl]-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(NC3=CC=2)C=2C=CC(=CC=2)C(F)(F)F)=C1CC AWUMODSCMDIQNR-UHFFFAOYSA-N 0.000 claims 1
- HJZVAQRBEZZCSL-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(1-methyl-2-pyrrolidin-3-ylindol-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C2CNCC2)=C1CC HJZVAQRBEZZCSL-UHFFFAOYSA-N 0.000 claims 1
- UXTCMOTXWSRBKR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(1-methyl-3,4-dihydro-2h-quinolin-6-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3CCCN(C)C3=CC=2)=C1CC UXTCMOTXWSRBKR-UHFFFAOYSA-N 0.000 claims 1
- JURMVRXAINHFGD-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(1-methylindol-3-yl)-2-oxo-1h-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(2-phenyl-1,3-benzoxazol-6-yl)-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C3=CC=CC=C3N(C)C=2)=C1CC.C1=C(C(O)=O)C(=O)NC(C=2C=C3OC(=NC3=CC=2)C=2C=CC=CC=2)=C1CC JURMVRXAINHFGD-UHFFFAOYSA-N 0.000 claims 1
- KGSQUUHWTGNDGG-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(2-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-7-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC=4CCN(C)CC=4C3=CC=2)=C1CC KGSQUUHWTGNDGG-UHFFFAOYSA-N 0.000 claims 1
- XSYLFYAHHWQDAR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-7-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC=4CN(C)CCC=4C3=CC=2)=C1CC XSYLFYAHHWQDAR-UHFFFAOYSA-N 0.000 claims 1
- WKFFRUOANMRSMS-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(2-methylindolizin-6-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C2=CN3C=C(C)C=C3C=C2)=C1CC WKFFRUOANMRSMS-UHFFFAOYSA-N 0.000 claims 1
- YYTFUUODBRRHIG-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(4-hydroxy-1-methylindol-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C(=C3C=CN(C)C3=CC=2)O)=C1CC YYTFUUODBRRHIG-UHFFFAOYSA-N 0.000 claims 1
- KMSPZSILDNDIPP-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-(6-methyl-4-pyrrolidin-1-ylpyrazolo[1,5-a]pyrazin-2-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C2=NN3C=C(C)N=C(C3=C2)N2CCCC2)=C1CC KMSPZSILDNDIPP-UHFFFAOYSA-N 0.000 claims 1
- DMGKORHKRCDPLU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(2-pyrrolidin-1-ylpropan-2-yl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C(C)(C)N2CCCC2)=C1CC DMGKORHKRCDPLU-UHFFFAOYSA-N 0.000 claims 1
- RNUUDMJMMZRKQI-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(methylaminomethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC)N(C)C3=CC=2)=C1CC RNUUDMJMMZRKQI-UHFFFAOYSA-N 0.000 claims 1
- WXBMHVLQQFFGFU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCOCC4)N(C)C3=CC=2)=C1CC WXBMHVLQQFFGFU-UHFFFAOYSA-N 0.000 claims 1
- GMLIPPFJJNWKLW-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCNCC4)N(C)C3=CC=2)=C1CC GMLIPPFJJNWKLW-UHFFFAOYSA-N 0.000 claims 1
- WNYZMDXASVTBNH-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(piperidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCCC4)N(C)C3=CC=2)=C1CC WNYZMDXASVTBNH-UHFFFAOYSA-N 0.000 claims 1
- IQIOLRNYCLEQLD-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=CC=2)=C1CC IQIOLRNYCLEQLD-UHFFFAOYSA-N 0.000 claims 1
- OOWHLWKDGZQMOR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(1-pyridin-3-ylethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)C=4C=NC=CC=4)N(C)C3=CC=2)=C1CC OOWHLWKDGZQMOR-UHFFFAOYSA-N 0.000 claims 1
- BFHKKAUTJNEXQV-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(1-pyridin-4-ylethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)C=4C=CN=CC=4)N(C)C3=CC=2)=C1CC BFHKKAUTJNEXQV-UHFFFAOYSA-N 0.000 claims 1
- BASHUAVPGAQHAN-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(2-methylcyclopropyl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CC4C(C4)C)N(C)C3=CC=2)=C1CC BASHUAVPGAQHAN-UHFFFAOYSA-N 0.000 claims 1
- YESNNQGPPSPDLX-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(2-methylpyrrolidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCC4)C)N(C)C3=CC=2)=C1CC YESNNQGPPSPDLX-UHFFFAOYSA-N 0.000 claims 1
- HLFFXZCJSSMVPR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(2-phenylpropan-2-ylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)(C)C=4C=CC=CC=4)N(C)C3=CC=2)=C1CC HLFFXZCJSSMVPR-UHFFFAOYSA-N 0.000 claims 1
- IEIOUQGMRRWUMU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(3-pyridin-2-ylpyrrolidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)C=4N=CC=CC=4)N(C)C3=CC=2)=C1CC IEIOUQGMRRWUMU-UHFFFAOYSA-N 0.000 claims 1
- VNAJUOZBRMGWNR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(3-pyridin-4-ylpyrrolidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)C=4C=CN=CC=4)N(C)C3=CC=2)=C1CC VNAJUOZBRMGWNR-UHFFFAOYSA-N 0.000 claims 1
- CIYOHLWNPURHMX-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(4-methyl-1,4-diazepan-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(C)CCC4)N(C)C3=CC=2)=C1CC CIYOHLWNPURHMX-UHFFFAOYSA-N 0.000 claims 1
- OAWYWTBCEWYVPM-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(C)CC4)N(C)C3=CC=2)=C1CC OAWYWTBCEWYVPM-UHFFFAOYSA-N 0.000 claims 1
- YDVBLLCFLRKHTF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(4-methylpiperidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(C)CC4)N(C)C3=CC=2)=C1CC YDVBLLCFLRKHTF-UHFFFAOYSA-N 0.000 claims 1
- WKOPIMSZUZVLRI-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(4-piperidin-1-ylpiperidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(CC4)N4CCCCC4)N(C)C3=CC=2)=C1CC WKOPIMSZUZVLRI-UHFFFAOYSA-N 0.000 claims 1
- FDRQPOIJYVAPHV-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(CC4)C(C)C)N(C)C3=CC=2)=C1CC FDRQPOIJYVAPHV-UHFFFAOYSA-N 0.000 claims 1
- IELVAUAJPGIILG-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(nonylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCCCCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC IELVAUAJPGIILG-UHFFFAOYSA-N 0.000 claims 1
- LKTDBYFGLDZBCG-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(octylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCCCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC LKTDBYFGLDZBCG-UHFFFAOYSA-N 0.000 claims 1
- QCEOVBDPCWMZHI-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(oxan-4-ylmethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CCOCC4)N(C)C3=CC=2)=C1CC QCEOVBDPCWMZHI-UHFFFAOYSA-N 0.000 claims 1
- IYMOINHEWACRQY-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(pentylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC IYMOINHEWACRQY-UHFFFAOYSA-N 0.000 claims 1
- RFMRFVMQAHZJHN-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(piperidin-4-ylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CCNCC4)N(C)C3=CC=2)=C1CC RFMRFVMQAHZJHN-UHFFFAOYSA-N 0.000 claims 1
- CYBYEULWLQHMEX-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(prop-2-ynylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC#C)N(C)C3=CC=2)=C1CC CYBYEULWLQHMEX-UHFFFAOYSA-N 0.000 claims 1
- DITYGYSTJDSCMY-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(pyridin-2-ylmethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4N=CC=CC=4)N(C)C3=CC=2)=C1CC DITYGYSTJDSCMY-UHFFFAOYSA-N 0.000 claims 1
- LSCOCBQAVATKCF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(pyridin-3-ylmethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=NC=CC=4)N(C)C3=CC=2)=C1CC LSCOCBQAVATKCF-UHFFFAOYSA-N 0.000 claims 1
- QHCJPTYPPATXAT-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[(pyridin-4-ylmethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CN=CC=4)N(C)C3=CC=2)=C1CC QHCJPTYPPATXAT-UHFFFAOYSA-N 0.000 claims 1
- JMYMTGXAEBUGEX-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylazetidin-3-yl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CN(C)C4)N(C)C3=CC=2)=C1CC JMYMTGXAEBUGEX-UHFFFAOYSA-N 0.000 claims 1
- PSAJGMYPKHWYTE-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylcyclobutyl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4(C)CCC4)N(C)C3=CC=2)=C1CC PSAJGMYPKHWYTE-UHFFFAOYSA-N 0.000 claims 1
- MZMFLLSKNZLMHJ-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylcyclopropyl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4(C)CC4)N(C)C3=CC=2)=C1CC MZMFLLSKNZLMHJ-UHFFFAOYSA-N 0.000 claims 1
- CJAKNEBMZYDZLC-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylpiperidin-2-yl)methylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4N(CCCC4)C)N(C)C3=CC=2)=C1CC CJAKNEBMZYDZLC-UHFFFAOYSA-N 0.000 claims 1
- VAAHXTXUBCRGDP-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylpiperidin-3-yl)methylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CN(C)CCC4)N(C)C3=CC=2)=C1CC VAAHXTXUBCRGDP-UHFFFAOYSA-N 0.000 claims 1
- CBBUCXGQOFEYPO-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(1-methylpiperidin-4-yl)methylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CCN(C)CC4)N(C)C3=CC=2)=C1CC CBBUCXGQOFEYPO-UHFFFAOYSA-N 0.000 claims 1
- XYSDIFFJVWAJBI-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(3-methylphenyl)methylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=C(C)C=CC=4)N(C)C3=CC=2)=C1CC XYSDIFFJVWAJBI-UHFFFAOYSA-N 0.000 claims 1
- FOLYMZQCIRLQCM-GASCZTMLSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(3r,5s)-3,4,5-trimethylpiperazin-1-yl]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H](C)N(C)[C@@H](C)C4)N(C)C3=CC=2)=C1CC FOLYMZQCIRLQCM-GASCZTMLSA-N 0.000 claims 1
- FRCGVMMXNHREMT-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[(4-methylphenyl)methylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CC(C)=CC=4)N(C)C3=CC=2)=C1CC FRCGVMMXNHREMT-UHFFFAOYSA-N 0.000 claims 1
- OZVHZOCWLUQDIU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[2-(methylamino)ethylamino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCNC)N(C)C3=CC=2)=C1CC OZVHZOCWLUQDIU-UHFFFAOYSA-N 0.000 claims 1
- VNGUSCJNWLXARA-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[2-(trifluoromethyl)piperidin-1-yl]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCCC4)C(F)(F)F)N(C)C3=CC=2)=C1CC VNGUSCJNWLXARA-UHFFFAOYSA-N 0.000 claims 1
- ORKHQYXVKVKEPR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[3-(methylamino)pyrrolidin-1-yl]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)NC)N(C)C3=CC=2)=C1CC ORKHQYXVKVKEPR-UHFFFAOYSA-N 0.000 claims 1
- BELLWEPYOLYMCC-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[4-(methylamino)piperidin-1-yl]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(CC4)NC)N(C)C3=CC=2)=C1CC BELLWEPYOLYMCC-UHFFFAOYSA-N 0.000 claims 1
- YJCRUDCCOQBPGG-RSAXXLAASA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[[(1s)-1-phenylethyl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN[C@@H](C)C=4C=CC=CC=4)N(C)C3=CC=2)=C1CC YJCRUDCCOQBPGG-RSAXXLAASA-N 0.000 claims 1
- IFZILXOFRSUSEL-SNVBAGLBSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[[(2r)-1,1,1-trifluoropropan-2-yl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN[C@H](C)C(F)(F)F)N(C)C3=CC=2)=C1CC IFZILXOFRSUSEL-SNVBAGLBSA-N 0.000 claims 1
- BFFKXPKTGLHYFV-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[methyl(piperidin-3-yl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C4CNCCC4)N(C)C3=CC=2)=C1CC BFFKXPKTGLHYFV-UHFFFAOYSA-N 0.000 claims 1
- LOFSUIQSUKQLHV-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[methyl(piperidin-4-yl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C4CCNCC4)N(C)C3=CC=2)=C1CC LOFSUIQSUKQLHV-UHFFFAOYSA-N 0.000 claims 1
- QHBMDAPXGOHSEL-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[methyl(pyridin-3-ylmethyl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CC=4C=NC=CC=4)N(C)C3=CC=2)=C1CC QHBMDAPXGOHSEL-UHFFFAOYSA-N 0.000 claims 1
- PTSQIWZGZSBDQT-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[1-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CC=4C=CN=CC=4)N(C)C3=CC=2)=C1CC PTSQIWZGZSBDQT-UHFFFAOYSA-N 0.000 claims 1
- YFQVPTIWQCNZSE-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-(methylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4CC(CN4C3=CC=2)NC)=C1CC YFQVPTIWQCNZSE-UHFFFAOYSA-N 0.000 claims 1
- LBLVQKNGKKCIAN-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[(3-hydroxyazetidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(O)C4)N(C)C3=CC=2)=C1CC LBLVQKNGKKCIAN-UHFFFAOYSA-N 0.000 claims 1
- KMNHBLQCZYWLFQ-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[(3-hydroxypiperidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(O)CCC4)N(C)C3=CC=2)=C1CC KMNHBLQCZYWLFQ-UHFFFAOYSA-N 0.000 claims 1
- ZTUWRACZPKQYER-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[(3-hydroxypyrrolidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(O)CC4)N(C)C3=CC=2)=C1CC ZTUWRACZPKQYER-UHFFFAOYSA-N 0.000 claims 1
- JRRITRYNAFQDOB-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[(3-methoxypyrrolidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)OC)N(C)C3=CC=2)=C1CC JRRITRYNAFQDOB-UHFFFAOYSA-N 0.000 claims 1
- OWLVKVUWAMFOBB-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[(4-hydroxypiperidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(O)CC4)N(C)C3=CC=2)=C1CC OWLVKVUWAMFOBB-UHFFFAOYSA-N 0.000 claims 1
- KXWVNSUDDREEAN-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[(2-methoxyphenyl)methylamino]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C(=CC=CC=4)OC)N(C)C3=CC=2)=C1CC KXWVNSUDDREEAN-UHFFFAOYSA-N 0.000 claims 1
- CVPINQGGCUHGHF-SFHVURJKSA-N 5-ethyl-4-hydroxy-6-[2-[[(2s)-2-methoxycarbonylpyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4[C@@H](CCC4)C(=O)OC)N(C)C3=CC=2)=C1CC CVPINQGGCUHGHF-SFHVURJKSA-N 0.000 claims 1
- QPCZUMGRXQQJAW-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[(3-methoxyphenyl)methylamino]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=C(OC)C=CC=4)N(C)C3=CC=2)=C1CC QPCZUMGRXQQJAW-UHFFFAOYSA-N 0.000 claims 1
- FSVHWVLZRPVOIF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[(4-methoxyphenyl)methylamino]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CC(OC)=CC=4)N(C)C3=CC=2)=C1CC FSVHWVLZRPVOIF-UHFFFAOYSA-N 0.000 claims 1
- XWKYBHLFOWIWIU-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[2-(2-methoxyethyl)piperidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCCC4)CCOC)N(C)C3=CC=2)=C1CC XWKYBHLFOWIWIU-UHFFFAOYSA-N 0.000 claims 1
- FGAQQEVLAJPPLB-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[2-(3-methoxypropyl)piperidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCCC4)CCCOC)N(C)C3=CC=2)=C1CC FGAQQEVLAJPPLB-UHFFFAOYSA-N 0.000 claims 1
- GTJQRWVXLSJFMS-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[2-methoxyethyl(methyl)amino]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CCOC)N(C)C3=CC=2)=C1CC GTJQRWVXLSJFMS-UHFFFAOYSA-N 0.000 claims 1
- TXJLJHWDWOUFKF-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[[3-(hydroxymethyl)azetidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CO)C4)N(C)C3=CC=2)=C1CC TXJLJHWDWOUFKF-UHFFFAOYSA-N 0.000 claims 1
- SVQWLCIXUQEPCM-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[2-[methyl(propyl)amino]-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N3CC(N(C)CCC)CC3=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC SVQWLCIXUQEPCM-UHFFFAOYSA-N 0.000 claims 1
- DRTDMIAESSEXIR-UHFFFAOYSA-N 5-ethyl-4-hydroxy-6-[7-(methylamino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-2-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4CCC(CN4C3=CC=2)NC)=C1CC DRTDMIAESSEXIR-UHFFFAOYSA-N 0.000 claims 1
- BGKBGHOXDAOVCV-UHFFFAOYSA-N 5-ethyl-6-(1-methyl-2-piperazin-2-ylindol-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C2NCCNC2)=C1CC BGKBGHOXDAOVCV-UHFFFAOYSA-N 0.000 claims 1
- MCCXNCVKEVXWEE-UHFFFAOYSA-N 5-ethyl-6-(1-methyl-2-pyrrolidin-3-ylindol-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C2CNCC2)=C1CC MCCXNCVKEVXWEE-UHFFFAOYSA-N 0.000 claims 1
- BYKWHHVALWMKBV-UHFFFAOYSA-N 5-ethyl-6-(1-methyl-3,4-dihydro-2h-quinolin-6-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3CCCN(C)C3=CC=2)=C1CC BYKWHHVALWMKBV-UHFFFAOYSA-N 0.000 claims 1
- MHBXOQLNUOAQHR-UHFFFAOYSA-N 5-ethyl-6-(1-methylpyrrolo[2,3-b]pyridin-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C)C3=NC=2)=C1CC MHBXOQLNUOAQHR-UHFFFAOYSA-N 0.000 claims 1
- MJTUFYYNWWDGJK-UHFFFAOYSA-N 5-ethyl-6-(2-ethyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-7-yl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2C=3CN(CC)CCC=3NC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC MJTUFYYNWWDGJK-UHFFFAOYSA-N 0.000 claims 1
- GKLMOTZYFYNMMU-UHFFFAOYSA-N 5-ethyl-6-(2-ethyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-7-yl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1N(CC)CCC(C2=CC=3)=C1NC2=CC=3C=1NC(=O)C(C(O)=O)=C(O)C=1CC GKLMOTZYFYNMMU-UHFFFAOYSA-N 0.000 claims 1
- MYHLDJMDUBAURV-UHFFFAOYSA-N 5-ethyl-6-(3-morpholin-4-yl-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4C(N5CCOCC5)CCN4C3=CC=2)=C1CC MYHLDJMDUBAURV-UHFFFAOYSA-N 0.000 claims 1
- YTWFYFPFCGDFFG-UHFFFAOYSA-N 5-ethyl-6-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3OCCN(C)C3=CC=2)=C1CC YTWFYFPFCGDFFG-UHFFFAOYSA-N 0.000 claims 1
- DRIBKIDKQQARBR-UHFFFAOYSA-N 5-ethyl-6-(5-fluoro-1,6-dimethylindol-2-yl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2N(C3=CC(C)=C(F)C=C3C=2)C)=C1CC DRIBKIDKQQARBR-UHFFFAOYSA-N 0.000 claims 1
- YWZOAICAKHJLBP-UHFFFAOYSA-N 5-ethyl-6-(6-ethyl-1h-indol-2-yl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound N1C2=CC(CC)=CC=C2C=C1C=1NC(=O)C(C(O)=O)=C(O)C=1CC YWZOAICAKHJLBP-UHFFFAOYSA-N 0.000 claims 1
- IYGUZEGLNXFOPO-UHFFFAOYSA-N 5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=4CCCCC=4N(C)C3=CC=2)=C1CC IYGUZEGLNXFOPO-UHFFFAOYSA-N 0.000 claims 1
- DOUUXBMZKHWQBB-UHFFFAOYSA-N 5-ethyl-6-[1-(2-hydroxyethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(1-methylindol-5-yl)-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C)C3=CC=2)=C1CC.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(CCO)C3=CC=2)=C1CC DOUUXBMZKHWQBB-UHFFFAOYSA-N 0.000 claims 1
- SHXMIMXEMDYOFP-UHFFFAOYSA-N 5-ethyl-6-[1-(4-fluorophenyl)indol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(C3=CC=2)C=2C=CC(F)=CC=2)=C1CC SHXMIMXEMDYOFP-UHFFFAOYSA-N 0.000 claims 1
- OVKWTHMCZPOWJX-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(1,4,5,6-tetrahydropyrimidin-2-yl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C=2NCCCN=2)=C1CC OVKWTHMCZPOWJX-UHFFFAOYSA-N 0.000 claims 1
- OPCGIEGIYORNKO-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(1-methylpiperazin-2-yl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C2N(CCNC2)C)=C1CC OPCGIEGIYORNKO-UHFFFAOYSA-N 0.000 claims 1
- ZUARQHVYINQDJZ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(1-pyrrolidin-1-ylethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C(C)N2CCCC2)=C1CC ZUARQHVYINQDJZ-UHFFFAOYSA-N 0.000 claims 1
- KNZBVFUEFLYNRF-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(2-morpholin-4-ylethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CCN4CCOCC4)N(C)C3=CC=2)=C1CC KNZBVFUEFLYNRF-UHFFFAOYSA-N 0.000 claims 1
- NNWKXVWKQQSDGU-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(2-piperidin-1-ylethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CCN4CCCCC4)N(C)C3=CC=2)=C1CC NNWKXVWKQQSDGU-UHFFFAOYSA-N 0.000 claims 1
- OXDLEUOABDPWOQ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(2-pyrrolidin-1-ylethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CCN4CCCC4)N(C)C3=CC=2)=C1CC OXDLEUOABDPWOQ-UHFFFAOYSA-N 0.000 claims 1
- WPDXGQIJXZTTJZ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(2-pyrrolidin-1-ylpropan-2-yl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C(C)(C)N2CCCC2)=C1CC WPDXGQIJXZTTJZ-UHFFFAOYSA-N 0.000 claims 1
- IUZJYUAZGFFUFC-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(methylaminomethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC)N(C)C3=CC=2)=C1CC IUZJYUAZGFFUFC-UHFFFAOYSA-N 0.000 claims 1
- WOODZSRTDYHECQ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCOCC4)N(C)C3=CC=2)=C1CC WOODZSRTDYHECQ-UHFFFAOYSA-N 0.000 claims 1
- VNWLBWRSGDHMBQ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCNCC4)N(C)C3=CC=2)=C1CC VNWLBWRSGDHMBQ-UHFFFAOYSA-N 0.000 claims 1
- HWLOFCCUXFPILT-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(piperidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCCC4)N(C)C3=CC=2)=C1CC HWLOFCCUXFPILT-UHFFFAOYSA-N 0.000 claims 1
- AOXPJGSASFUBCM-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3,4-dicarboxylic acid Chemical compound N1C(=O)C(C(O)=O)=C(C(O)=O)C(CC)=C1C1=CC=C(N(C)C(CN2CCCC2)=C2)C2=C1 AOXPJGSASFUBCM-UHFFFAOYSA-N 0.000 claims 1
- WCYAWIJRODWSFY-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=CC=2)=C1CC WCYAWIJRODWSFY-UHFFFAOYSA-N 0.000 claims 1
- QNFLUILBVOLTNT-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-(pyrrolidin-1-ylmethyl)pyrrolo[3,2-b]pyridin-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2N=C3C=C(CN4CCCC4)N(C)C3=CC=2)=C1CC QNFLUILBVOLTNT-UHFFFAOYSA-N 0.000 claims 1
- GNCYKZPEISJPSI-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[(2-methylpyrrolidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCC4)C)N(C)C3=CC=2)=C1CC GNCYKZPEISJPSI-UHFFFAOYSA-N 0.000 claims 1
- QADVHQIFYWAKMA-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[(2-phenylpyrrolidin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCC4)C=4C=CC=CC=4)N(C)C3=CC=2)=C1CC QADVHQIFYWAKMA-UHFFFAOYSA-N 0.000 claims 1
- HDWJONVAVFCZDV-PKLMIRHRSA-N 5-ethyl-6-[1-methyl-2-[(2r)-pyrrolidin-2-yl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)[C@@H]2NCCC2)=C1CC HDWJONVAVFCZDV-PKLMIRHRSA-N 0.000 claims 1
- HDWJONVAVFCZDV-NTISSMGPSA-N 5-ethyl-6-[1-methyl-2-[(2s)-pyrrolidin-2-yl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)[C@H]2NCCC2)=C1CC HDWJONVAVFCZDV-NTISSMGPSA-N 0.000 claims 1
- YOZDNDJCJBYAKL-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(C)CC4)N(C)C3=CC=2)=C1CC YOZDNDJCJBYAKL-UHFFFAOYSA-N 0.000 claims 1
- CQRFOAGGFAFFRZ-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(CC4)C(C)C)N(C)C3=CC=2)=C1CC CQRFOAGGFAFFRZ-UHFFFAOYSA-N 0.000 claims 1
- IOHZRWZGNNQUHA-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[(pyridin-2-ylmethylamino)methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4N=CC=CC=4)N(C)C3=CC=2)=C1CC IOHZRWZGNNQUHA-UHFFFAOYSA-N 0.000 claims 1
- VHNRPEIJPAMIOE-UHFFFAOYSA-N 5-ethyl-6-[1-methyl-2-[[3-(methylamino)pyrrolidin-1-yl]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)NC)N(C)C3=CC=2)=C1CC VHNRPEIJPAMIOE-UHFFFAOYSA-N 0.000 claims 1
- IMSJEXYOLSPFDU-MRXNPFEDSA-N 5-ethyl-6-[1-methyl-2-[[[(1r)-1-phenylethyl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN[C@H](C)C=4C=CC=CC=4)N(C)C3=CC=2)=C1CC IMSJEXYOLSPFDU-MRXNPFEDSA-N 0.000 claims 1
- UQUOXIMOPOBIPY-HSZRJFAPSA-N 5-ethyl-6-[1-methyl-2-[[[(1r)-1-phenylpropyl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound N([C@H](CC)C=1C=CC=CC=1)CC(N(C1=CC=2)C)=CC1=CC=2C=1NC(=O)C(C(O)=O)=CC=1CC UQUOXIMOPOBIPY-HSZRJFAPSA-N 0.000 claims 1
- IMSJEXYOLSPFDU-INIZCTEOSA-N 5-ethyl-6-[1-methyl-2-[[[(1s)-1-phenylethyl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN[C@@H](C)C=4C=CC=CC=4)N(C)C3=CC=2)=C1CC IMSJEXYOLSPFDU-INIZCTEOSA-N 0.000 claims 1
- UQUOXIMOPOBIPY-QHCPKHFHSA-N 5-ethyl-6-[1-methyl-2-[[[(1s)-1-phenylpropyl]amino]methyl]indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound N([C@@H](CC)C=1C=CC=CC=1)CC(N(C1=CC=2)C)=CC1=CC=2C=1NC(=O)C(C(O)=O)=CC=1CC UQUOXIMOPOBIPY-QHCPKHFHSA-N 0.000 claims 1
- BHGWAYPKDAJJSK-UHFFFAOYSA-N 5-ethyl-6-[2-(ethylaminomethyl)-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC BHGWAYPKDAJJSK-UHFFFAOYSA-N 0.000 claims 1
- IIGSQAXCZKPEBM-UHFFFAOYSA-N 5-ethyl-6-[2-(ethylaminomethyl)-1h-indol-6-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2NC(CNCC)=CC2=CC=C1C=1NC(=O)C(C(O)=O)=C(O)C=1CC IIGSQAXCZKPEBM-UHFFFAOYSA-N 0.000 claims 1
- GJQAGWPODSLOFE-UHFFFAOYSA-N 5-ethyl-6-[2-(ethylaminomethyl)-3-fluoro-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCC)=C(F)C2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC GJQAGWPODSLOFE-UHFFFAOYSA-N 0.000 claims 1
- XSIVOEACITYVMC-UHFFFAOYSA-N 5-ethyl-6-[2-[(2-fluoroethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCF)N(C)C3=CC=2)=C1CC XSIVOEACITYVMC-UHFFFAOYSA-N 0.000 claims 1
- CADWETNNTUCVEH-UHFFFAOYSA-N 5-ethyl-6-[2-[(3-fluoroazetidin-1-yl)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(F)C4)N(C)C3=CC=2)=C1CC CADWETNNTUCVEH-UHFFFAOYSA-N 0.000 claims 1
- AFBPHIVJAMBAPM-UHFFFAOYSA-N 5-ethyl-6-[2-[(3-hydroxypyrrolidin-1-yl)methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(O)CC4)N(C)C3=CC=2)=C1CC AFBPHIVJAMBAPM-UHFFFAOYSA-N 0.000 claims 1
- LKXZBUZJHNHGHR-UHFFFAOYSA-N 5-ethyl-6-[2-[(heptylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC LKXZBUZJHNHGHR-UHFFFAOYSA-N 0.000 claims 1
- KNONDCOPQQOFRJ-UHFFFAOYSA-N 5-ethyl-6-[2-[(hexylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC KNONDCOPQQOFRJ-UHFFFAOYSA-N 0.000 claims 1
- UKLORIZRZPOCKT-UHFFFAOYSA-N 5-ethyl-6-[2-[[(2-fluorophenyl)methylamino]methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C(=CC=CC=4)F)N(C)C3=CC=2)=C1CC UKLORIZRZPOCKT-UHFFFAOYSA-N 0.000 claims 1
- ZBDZMILOWTVUFQ-QGZVFWFLSA-N 5-ethyl-6-[2-[[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4[C@H](CCC4)CO)N(C)C3=CC=2)=C1CC ZBDZMILOWTVUFQ-QGZVFWFLSA-N 0.000 claims 1
- AUIYJKHXXDXKOF-UHFFFAOYSA-N 5-ethyl-6-[2-[[(3-fluorophenyl)methylamino]methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=C(F)C=CC=4)N(C)C3=CC=2)=C1CC AUIYJKHXXDXKOF-UHFFFAOYSA-N 0.000 claims 1
- XLQZGLIOZQHLGI-MRXNPFEDSA-N 5-ethyl-6-[2-[[(3r)-3-fluoropyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@H](F)CC4)N(C)C3=CC=2)=C1CC XLQZGLIOZQHLGI-MRXNPFEDSA-N 0.000 claims 1
- SJQPTGIZVISUTF-CQSZACIVSA-N 5-ethyl-6-[2-[[(3r)-3-fluoropyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@H](F)CC4)N(C)C3=CC=2)=C1CC SJQPTGIZVISUTF-CQSZACIVSA-N 0.000 claims 1
- PNGNKMZOAXZKNN-UHFFFAOYSA-N 5-ethyl-6-[2-[[(4-fluorophenyl)methylamino]methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CC(F)=CC=4)N(C)C3=CC=2)=C1CC PNGNKMZOAXZKNN-UHFFFAOYSA-N 0.000 claims 1
- XONZGCCSTACTJY-UHFFFAOYSA-N 5-ethyl-6-[2-[ethyl(methyl)amino]-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N3CC(N(C)CC)CC3=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC XONZGCCSTACTJY-UHFFFAOYSA-N 0.000 claims 1
- UJXVMQBTJNPPFC-UHFFFAOYSA-N 5-ethyl-6-[3-fluoro-1-methyl-2-(methylaminomethyl)indol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(F)=C(CNC)N(C)C3=CC=2)=C1CC UJXVMQBTJNPPFC-UHFFFAOYSA-N 0.000 claims 1
- JKIVQEMFQXQASX-UHFFFAOYSA-N 5-ethyl-6-[3-fluoro-1-methyl-2-[(propan-2-ylamino)methyl]indol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(F)=C(CNC(C)C)N(C)C3=CC=2)=C1CC JKIVQEMFQXQASX-UHFFFAOYSA-N 0.000 claims 1
- XYKIDPUHCMFHOY-UHFFFAOYSA-N 5-ethyl-6-[4-fluoro-1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=C3C=C(CN4CCCC4)N(C)C3=CC=2)F)=C1CC XYKIDPUHCMFHOY-UHFFFAOYSA-N 0.000 claims 1
- IOXVLZIQZNPIQQ-UHFFFAOYSA-N 5-ethyl-6-[6-methoxy-1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCOCC4)=CC=3C=2)OC)=C1CC IOXVLZIQZNPIQQ-UHFFFAOYSA-N 0.000 claims 1
- AJLHRKIDJFHKHQ-UHFFFAOYSA-N 5-ethyl-6-[6-methoxy-1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCCC4)=CC=3C=2)OC)=C1CC AJLHRKIDJFHKHQ-UHFFFAOYSA-N 0.000 claims 1
- BIZLCOUCUDHQKZ-UHFFFAOYSA-N 5-ethyl-6-[6-methyl-5-(pyrrolidin-1-ylmethyl)thieno[2,3-b]pyrrol-2-yl]-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(=O)NC(C=2SC=3N(C)C(CN4CCCC4)=CC=3C=2)=C1CC BIZLCOUCUDHQKZ-UHFFFAOYSA-N 0.000 claims 1
- QWXRBGANZTVJGY-UHFFFAOYSA-N 5-ethyl-6-[7-fluoro-1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCOCC4)N(C)C3=C(F)C=2)=C1CC QWXRBGANZTVJGY-UHFFFAOYSA-N 0.000 claims 1
- SBGCBSCKJJFYAF-UHFFFAOYSA-N 5-ethyl-6-[7-fluoro-1-methyl-2-(piperidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCCC4)N(C)C3=C(F)C=2)=C1CC SBGCBSCKJJFYAF-UHFFFAOYSA-N 0.000 claims 1
- WAVUQHPUOONKGP-UHFFFAOYSA-N 5-ethyl-6-[7-fluoro-1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=C(F)C=2)=C1CC WAVUQHPUOONKGP-UHFFFAOYSA-N 0.000 claims 1
- QAFRZMGNSYNKHP-UHFFFAOYSA-N 6-(2-amino-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl)-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4CC(N)CN4C3=CC=2)=C1C QAFRZMGNSYNKHP-UHFFFAOYSA-N 0.000 claims 1
- QYUDRUHPUBHJAY-UHFFFAOYSA-N 6-(2-amino-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl)-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4CC(N)CN4C3=CC=2)=C1CC QYUDRUHPUBHJAY-UHFFFAOYSA-N 0.000 claims 1
- WIHAZWOOHUSAHH-UHFFFAOYSA-N 6-(3-cyano-1-methyl-2-pyrrolidin-1-ylindol-5-yl)-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(C#N)=C(N4CCCC4)N(C)C3=CC=2)=C1CC WIHAZWOOHUSAHH-UHFFFAOYSA-N 0.000 claims 1
- ZQQPQAWLQHGPLP-UHFFFAOYSA-N 6-(9h-carbazol-2-yl)-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(C4=CC=CC=C4N3)=CC=2)=C1CC ZQQPQAWLQHGPLP-UHFFFAOYSA-N 0.000 claims 1
- FRWUNWTULJBGIK-NHYQQRJDSA-N 6-[(2s,3s)-2-(aminomethyl)-3-(methylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4[C@@H](NC)[C@@H](CN)CN4C3=CC=2)=C1CC FRWUNWTULJBGIK-NHYQQRJDSA-N 0.000 claims 1
- AAYHOCDDAPGACC-OJNIYTAOSA-N 6-[(7r,9r)-7-amino-9-(methylamino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-2-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4[C@H](NC)C[C@@H](N)CN4C3=CC=2)=C1CC AAYHOCDDAPGACC-OJNIYTAOSA-N 0.000 claims 1
- JJEJAVNDYROVAB-UHFFFAOYSA-N 6-[1,6-dimethyl-2-(morpholin-4-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCOCC4)=CC=3C=2)C)=C1CC JJEJAVNDYROVAB-UHFFFAOYSA-N 0.000 claims 1
- LXXUHRLHKWLRPP-UHFFFAOYSA-N 6-[1,6-dimethyl-2-(piperidin-1-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCCCC4)=CC=3C=2)C)=C1CC LXXUHRLHKWLRPP-UHFFFAOYSA-N 0.000 claims 1
- BEVSEFWRMQELAG-UHFFFAOYSA-N 6-[1,6-dimethyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCCC4)=CC=3C=2)C)=C1CC BEVSEFWRMQELAG-UHFFFAOYSA-N 0.000 claims 1
- FAPBBEPVBFTMNJ-UHFFFAOYSA-N 6-[1,7-dimethyl-2-(morpholin-4-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCOCC4)N(C)C3=C(C)C=2)=C1CC FAPBBEPVBFTMNJ-UHFFFAOYSA-N 0.000 claims 1
- YHKKTUMWJUUZHN-UHFFFAOYSA-N 6-[1,7-dimethyl-2-(piperidin-1-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCCC4)N(C)C3=C(C)C=2)=C1CC YHKKTUMWJUUZHN-UHFFFAOYSA-N 0.000 claims 1
- RLWSVNJULNNUJS-UHFFFAOYSA-N 6-[1,7-dimethyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCCC4)N(C)C3=C(C)C=2)=C1CC RLWSVNJULNNUJS-UHFFFAOYSA-N 0.000 claims 1
- YPQCGLUCTHZRHT-UHFFFAOYSA-N 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=CN(CC4OCCO4)C3=CC=2)=C1CC YPQCGLUCTHZRHT-UHFFFAOYSA-N 0.000 claims 1
- YAUJJJRAYZABGE-UHFFFAOYSA-N 6-[2-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-ylmethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC5NCCCC5C4)N(C)C3=CC=2)=C1CC YAUJJJRAYZABGE-UHFFFAOYSA-N 0.000 claims 1
- MKTMZTXHYKIOSY-UHFFFAOYSA-N 6-[2-(1,4-diazepan-1-ylmethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCNCCC4)N(C)C3=CC=2)=C1CC MKTMZTXHYKIOSY-UHFFFAOYSA-N 0.000 claims 1
- WDZLNOCKIHYERO-UHFFFAOYSA-N 6-[2-(2,5-diazabicyclo[2.2.1]heptan-2-ylmethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C5CC(NC5)C4)N(C)C3=CC=2)=C1CC WDZLNOCKIHYERO-UHFFFAOYSA-N 0.000 claims 1
- GRPCKLSSQAGQLB-UHFFFAOYSA-N 6-[2-(2,5-diazabicyclo[2.2.1]heptan-2-ylmethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C5CC(NC5)C4)N(C)C3=CC=2)=C1CC GRPCKLSSQAGQLB-UHFFFAOYSA-N 0.000 claims 1
- ALIMRMUTCSJGRR-UHFFFAOYSA-N 6-[2-(3,4-dihydro-1h-isoquinolin-2-ylmethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC5=CC=CC=C5CC4)N(C)C3=CC=2)=C1CC ALIMRMUTCSJGRR-UHFFFAOYSA-N 0.000 claims 1
- PBFACCARCNHVOX-UHFFFAOYSA-N 6-[2-(4,5-dihydro-1h-imidazol-2-yl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C=2NCCN=2)=C1CC PBFACCARCNHVOX-UHFFFAOYSA-N 0.000 claims 1
- JXBBHGVFHGQRNB-UHFFFAOYSA-N 6-[2-(5,7-dihydropyrrolo[3,4-b]pyridin-6-ylmethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC5=NC=CC=C5C4)N(C)C3=CC=2)=C1CC JXBBHGVFHGQRNB-UHFFFAOYSA-N 0.000 claims 1
- XMQGBGSYKPEPOW-UHFFFAOYSA-N 6-[2-(aminomethyl)-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN)N(C)C3=CC=2)=C1C XMQGBGSYKPEPOW-UHFFFAOYSA-N 0.000 claims 1
- HOLMKESJZBBACI-UHFFFAOYSA-N 6-[2-(aminomethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN)N(C)C3=CC=2)=C1CC HOLMKESJZBBACI-UHFFFAOYSA-N 0.000 claims 1
- DRUKFIBTJWIECT-UHFFFAOYSA-N 6-[2-(aminomethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN)N(C)C3=CC=2)=C1CC DRUKFIBTJWIECT-UHFFFAOYSA-N 0.000 claims 1
- KHQWONZPBOJALU-UHFFFAOYSA-N 6-[2-(anilinomethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC KHQWONZPBOJALU-UHFFFAOYSA-N 0.000 claims 1
- IJZGMZMTOYYKKC-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C=3NC(=O)C(C(O)=O)=C(O)C=3)=CC=C2N(C)C=1CN1CCC1 IJZGMZMTOYYKKC-UHFFFAOYSA-N 0.000 claims 1
- IYBBCVUQYMKWFC-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC4)N(C)C3=CC=2)=C1C IYBBCVUQYMKWFC-UHFFFAOYSA-N 0.000 claims 1
- YGPDNAJGPRXDSQ-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-5-(4-fluorophenyl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C=3C=CC(F)=CC=3)=CC=C2N(C)C=1CN1CCC1 YGPDNAJGPRXDSQ-UHFFFAOYSA-N 0.000 claims 1
- XYUBWAJKIJGBAU-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-5-cyclopropyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C3CC3)=CC=C2N(C)C=1CN1CCC1 XYUBWAJKIJGBAU-UHFFFAOYSA-N 0.000 claims 1
- MWBIEZFKXNMFNE-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3,4-dicarboxylic acid Chemical compound N1C(=O)C(C(O)=O)=C(C(O)=O)C(CC)=C1C1=CC=C(N(C)C(CN2CCC2)=C2)C2=C1 MWBIEZFKXNMFNE-UHFFFAOYSA-N 0.000 claims 1
- GPCOFPLGNMOVRO-UHFFFAOYSA-N 6-[2-(azetidin-1-ylmethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC4)N(C)C3=CC=2)=C1CC GPCOFPLGNMOVRO-UHFFFAOYSA-N 0.000 claims 1
- VAWPXAIHTYKFRX-UHFFFAOYSA-N 6-[2-(butylaminomethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC VAWPXAIHTYKFRX-UHFFFAOYSA-N 0.000 claims 1
- VLFSAHXESFKOSQ-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-1,6-dimethylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound CC=1C=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=CC=1CC VLFSAHXESFKOSQ-UHFFFAOYSA-N 0.000 claims 1
- PJEIONLNUFJWQR-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-1,7-dimethylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C(C)=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=CC=1CC PJEIONLNUFJWQR-UHFFFAOYSA-N 0.000 claims 1
- HGMZJNYIZQLHHG-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C HGMZJNYIZQLHHG-UHFFFAOYSA-N 0.000 claims 1
- JTGMVFBPENUBNZ-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=CC=1CC JTGMVFBPENUBNZ-UHFFFAOYSA-N 0.000 claims 1
- YYNYZOYDXWDZNE-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1CC YYNYZOYDXWDZNE-UHFFFAOYSA-N 0.000 claims 1
- ZDJYTQQWQNFJHI-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)-7-fluoro-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C(F)=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=CC=1CC ZDJYTQQWQNFJHI-UHFFFAOYSA-N 0.000 claims 1
- XOVROGHSOXVODX-UHFFFAOYSA-N 6-[2-(diethylaminomethyl)imidazo[1,2-a]pyridin-6-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=CC2=NC(CN(CC)CC)=CN2C=C1C=1NC(=O)C(C(O)=O)=CC=1CC XOVROGHSOXVODX-UHFFFAOYSA-N 0.000 claims 1
- UYWBRNZKJOEUSX-UHFFFAOYSA-N 6-[2-(dimethylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=C2N3CC(N(C)C)CC3=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C UYWBRNZKJOEUSX-UHFFFAOYSA-N 0.000 claims 1
- XOCQVEXMBBORQR-UHFFFAOYSA-N 6-[2-(dimethylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4CC(CN4C3=CC=2)N(C)C)=C1CC XOCQVEXMBBORQR-UHFFFAOYSA-N 0.000 claims 1
- BBNFIABVLQSTGR-UHFFFAOYSA-N 6-[2-(ethylaminomethyl)-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C BBNFIABVLQSTGR-UHFFFAOYSA-N 0.000 claims 1
- MCRWVQXONOSJGZ-UHFFFAOYSA-N 6-[2-(ethylaminomethyl)-1h-indol-6-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2NC(CNCC)=CC2=CC=C1C=1NC(=O)C(C(O)=O)=C(O)C=1C MCRWVQXONOSJGZ-UHFFFAOYSA-N 0.000 claims 1
- PPRXBICYFJGPCX-UHFFFAOYSA-N 6-[2-[(1,3-difluoropropan-2-ylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(CF)CF)N(C)C3=CC=2)=C1CC PPRXBICYFJGPCX-UHFFFAOYSA-N 0.000 claims 1
- MJEPXXGJQKNIHN-UHFFFAOYSA-N 6-[2-[(2,2-dimethylpropylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC(C)(C)C)N(C)C3=CC=2)=C1CC MJEPXXGJQKNIHN-UHFFFAOYSA-N 0.000 claims 1
- WBRQMAZPOHIYDP-UHFFFAOYSA-N 6-[2-[(2-aminoethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCN)N(C)C3=CC=2)=C1C WBRQMAZPOHIYDP-UHFFFAOYSA-N 0.000 claims 1
- GCIKPSHTNCBGIN-UHFFFAOYSA-N 6-[2-[(2-aminoethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCN)N(C)C3=CC=2)=C1CC GCIKPSHTNCBGIN-UHFFFAOYSA-N 0.000 claims 1
- TWJCGVZGZKPNFH-UHFFFAOYSA-N 6-[2-[(3,3-difluoroazetidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(F)(F)C4)N(C)C3=CC=2)=C1CC TWJCGVZGZKPNFH-UHFFFAOYSA-N 0.000 claims 1
- YNGXABFKXGPQCN-UHFFFAOYSA-N 6-[2-[(3,3-difluoropyrrolidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(F)(F)CC4)N(C)C3=CC=2)=C1CC YNGXABFKXGPQCN-UHFFFAOYSA-N 0.000 claims 1
- LCZQGNXIPFUJFA-UHFFFAOYSA-N 6-[2-[(3-aminoazetidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(N)C4)N(C)C3=CC=2)=C1CC LCZQGNXIPFUJFA-UHFFFAOYSA-N 0.000 claims 1
- VPIHVILVLIBUBS-UHFFFAOYSA-N 6-[2-[(3-carboxyazetidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(C4)C(O)=O)N(C)C3=CC=2)=C1CC VPIHVILVLIBUBS-UHFFFAOYSA-N 0.000 claims 1
- BMLCBKFOZZIDIN-UHFFFAOYSA-N 6-[2-[(4,4-difluoropiperidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(F)(F)CC4)N(C)C3=CC=2)=C1CC BMLCBKFOZZIDIN-UHFFFAOYSA-N 0.000 claims 1
- QZLLCNZQYUDCPM-UHFFFAOYSA-N 6-[2-[(4-acetylpiperazin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(CC4)C(C)=O)N(C)C3=CC=2)=C1CC QZLLCNZQYUDCPM-UHFFFAOYSA-N 0.000 claims 1
- SQWNOKVKVLFKIA-UHFFFAOYSA-N 6-[2-[(4-acetylpiperazin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCN(CC4)C(C)=O)N(C)C3=CC=2)=C1CC SQWNOKVKVLFKIA-UHFFFAOYSA-N 0.000 claims 1
- WJBQGYNMQUWCGU-UHFFFAOYSA-N 6-[2-[(4-aminopiperidin-1-yl)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(N)CC4)N(C)C3=CC=2)=C1CC WJBQGYNMQUWCGU-UHFFFAOYSA-N 0.000 claims 1
- AKHUUOZAFXGRBL-UHFFFAOYSA-N 6-[2-[(benzylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC AKHUUOZAFXGRBL-UHFFFAOYSA-N 0.000 claims 1
- IGJXWDVFDBULRA-UHFFFAOYSA-N 6-[2-[(benzylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC IGJXWDVFDBULRA-UHFFFAOYSA-N 0.000 claims 1
- ABAABTPBJGOTNM-UHFFFAOYSA-N 6-[2-[(butan-2-ylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNC(C)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C ABAABTPBJGOTNM-UHFFFAOYSA-N 0.000 claims 1
- CGXCSYLSICCARF-UHFFFAOYSA-N 6-[2-[(butan-2-ylamino)methyl]-1h-indol-6-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C2NC(CNC(C)CC)=CC2=CC=C1C=1NC(=O)C(C(O)=O)=C(O)C=1CC CGXCSYLSICCARF-UHFFFAOYSA-N 0.000 claims 1
- UVIDTOPVXZJKKJ-UHFFFAOYSA-N 6-[2-[(cyclobutylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CCC4)N(C)C3=CC=2)=C1C UVIDTOPVXZJKKJ-UHFFFAOYSA-N 0.000 claims 1
- IARYTKMIUPFOTR-UHFFFAOYSA-N 6-[2-[(cyclobutylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CCC4)N(C)C3=CC=2)=C1CC IARYTKMIUPFOTR-UHFFFAOYSA-N 0.000 claims 1
- NAQOSNLTMCBPRD-UHFFFAOYSA-N 6-[2-[(cyclobutylmethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CCC4)N(C)C3=CC=2)=C1CC NAQOSNLTMCBPRD-UHFFFAOYSA-N 0.000 claims 1
- HYWMXDHXFGTCLU-UHFFFAOYSA-N 6-[2-[(cycloheptylmethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CCCCCC4)N(C)C3=CC=2)=C1CC HYWMXDHXFGTCLU-UHFFFAOYSA-N 0.000 claims 1
- KMCCINGOAAQXKA-UHFFFAOYSA-N 6-[2-[(cyclohexylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CCCCC4)N(C)C3=CC=2)=C1CC KMCCINGOAAQXKA-UHFFFAOYSA-N 0.000 claims 1
- YKHCMFKZEFNVSB-UHFFFAOYSA-N 6-[2-[(cyclopentylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CCCC4)N(C)C3=CC=2)=C1CC YKHCMFKZEFNVSB-UHFFFAOYSA-N 0.000 claims 1
- IQYOXDHDEPALSQ-UHFFFAOYSA-N 6-[2-[(cyclopentylmethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CCCC4)N(C)C3=CC=2)=C1CC IQYOXDHDEPALSQ-UHFFFAOYSA-N 0.000 claims 1
- GHODNTJWPGBGHV-UHFFFAOYSA-N 6-[2-[(cyclopropylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CC4)N(C)C3=CC=2)=C1C GHODNTJWPGBGHV-UHFFFAOYSA-N 0.000 claims 1
- AHFYVLYANFOYCO-UHFFFAOYSA-N 6-[2-[(cyclopropylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC4CC4)N(C)C3=CC=2)=C1CC AHFYVLYANFOYCO-UHFFFAOYSA-N 0.000 claims 1
- FHCZPVNXSBHGOA-UHFFFAOYSA-N 6-[2-[(cyclopropylmethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CC4)N(C)C3=CC=2)=C1C FHCZPVNXSBHGOA-UHFFFAOYSA-N 0.000 claims 1
- SFSQOALOZVTRGL-UHFFFAOYSA-N 6-[2-[(cyclopropylmethylamino)methyl]-1-methylindol-5-yl]-5-(4-fluorophenyl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C2=CC(C3=C(C(O)=C(C(O)=O)C(=O)N3)C=3C=CC(F)=CC=3)=CC=C2N(C)C=1CNCC1CC1 SFSQOALOZVTRGL-UHFFFAOYSA-N 0.000 claims 1
- DGGHAGJJNSNUFP-UHFFFAOYSA-N 6-[2-[(cyclopropylmethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCC4CC4)N(C)C3=CC=2)=C1CC DGGHAGJJNSNUFP-UHFFFAOYSA-N 0.000 claims 1
- FHGKMEMSQRYNKC-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1,6-dimethylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN(C)C)=CC=3C=2)C)=C1CC FHGKMEMSQRYNKC-UHFFFAOYSA-N 0.000 claims 1
- SQWRNXDPONMLMC-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1,7-dimethylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=C(C)C=2)=C1CC SQWRNXDPONMLMC-UHFFFAOYSA-N 0.000 claims 1
- WLZDNAUKVWZXTE-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(C)C)=CC2=CC=1C1=CC(O)=C(C(O)=O)C(=O)N1 WLZDNAUKVWZXTE-UHFFFAOYSA-N 0.000 claims 1
- JLMCDZYAWSTZMJ-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-5-propan-2-yl-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=CC=2)=C1C(C)C JLMCDZYAWSTZMJ-UHFFFAOYSA-N 0.000 claims 1
- QNFNVBHSHTUNKN-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-2-oxo-5-propyl-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=CC=2)=C1CCC QNFNVBHSHTUNKN-UHFFFAOYSA-N 0.000 claims 1
- LDOGXIAANRXUJF-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C LDOGXIAANRXUJF-UHFFFAOYSA-N 0.000 claims 1
- WWNRQAWTHYDLFX-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-(4-fluorophenyl)-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CN(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C1=CC=C(F)C=C1 WWNRQAWTHYDLFX-UHFFFAOYSA-N 0.000 claims 1
- DZAPFMQAECCELO-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3,4-dicarboxylic acid Chemical compound N1C(=O)C(C(O)=O)=C(C(O)=O)C(CC)=C1C1=CC=C(N(C)C(CN(C)C)=C2)C2=C1 DZAPFMQAECCELO-UHFFFAOYSA-N 0.000 claims 1
- MVKRBLJIVXVOBO-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=CC=2)=C1CC MVKRBLJIVXVOBO-UHFFFAOYSA-N 0.000 claims 1
- XBUYXFOWZZAWON-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=CC=2)=C1CC XBUYXFOWZZAWON-UHFFFAOYSA-N 0.000 claims 1
- GBMYWWRVRPBUIR-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-1h-indol-6-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3NC(CN(C)C)=CC3=CC=2)=C1CC GBMYWWRVRPBUIR-UHFFFAOYSA-N 0.000 claims 1
- FAEISHWDXHIBKQ-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]-7-fluoro-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C)N(C)C3=C(F)C=2)=C1CC FAEISHWDXHIBKQ-UHFFFAOYSA-N 0.000 claims 1
- XQGPMCJFYVUBJO-UHFFFAOYSA-N 6-[2-[(dimethylamino)methyl]imidazo[1,2-a]pyridin-6-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.C1=C(C(O)=O)C(=O)NC(C2=CN3C=C(CN(C)C)N=C3C=C2)=C1CC XQGPMCJFYVUBJO-UHFFFAOYSA-N 0.000 claims 1
- ZJCGSQWYVASKPQ-UHFFFAOYSA-N 6-[2-[(tert-butylamino)methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)(C)C)N(C)C3=CC=2)=C1C ZJCGSQWYVASKPQ-UHFFFAOYSA-N 0.000 claims 1
- CWLMGUGZWPZLFX-UHFFFAOYSA-N 6-[2-[(tert-butylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)(C)C)N(C)C3=CC=2)=C1CC CWLMGUGZWPZLFX-UHFFFAOYSA-N 0.000 claims 1
- FUTKEHOEWOLASX-UHFFFAOYSA-N 6-[2-[(tert-butylamino)methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNC(C)(C)C)N(C)C3=CC=2)=C1CC FUTKEHOEWOLASX-UHFFFAOYSA-N 0.000 claims 1
- IUDNOIUPAIYRRU-UHFFFAOYSA-N 6-[2-[(tert-butylamino)methyl]-3-fluoro-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(F)=C(CNC(C)(C)C)N(C)C3=CC=2)=C1CC IUDNOIUPAIYRRU-UHFFFAOYSA-N 0.000 claims 1
- NPDQRSLAXWJHHA-UHFFFAOYSA-N 6-[2-[2-(dimethylamino)ethyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CCN(C)C)N(C)C3=CC=2)=C1CC NPDQRSLAXWJHHA-UHFFFAOYSA-N 0.000 claims 1
- GZKQPCOOMQLNPK-UHFFFAOYSA-N 6-[2-[2-(dimethylamino)propan-2-yl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C(C)(C)N(C)C)=C1CC GZKQPCOOMQLNPK-UHFFFAOYSA-N 0.000 claims 1
- UHCOJFLMPFLLAV-UHFFFAOYSA-N 6-[2-[2-(dimethylamino)propan-2-yl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(N(C)C3=CC=2)C(C)(C)N(C)C)=C1CC UHCOJFLMPFLLAV-UHFFFAOYSA-N 0.000 claims 1
- DSCXFTAMRUYCOT-GASCZTMLSA-N 6-[2-[[(2r,6s)-2,6-dimethylmorpholin-4-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H](C)O[C@@H](C)C4)N(C)C3=CC=2)=C1CC DSCXFTAMRUYCOT-GASCZTMLSA-N 0.000 claims 1
- XEMNAIFZUFSELF-NRFANRHFSA-N 6-[2-[[(2s)-2-(anilinomethyl)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4[C@@H](CCC4)CNC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC XEMNAIFZUFSELF-NRFANRHFSA-N 0.000 claims 1
- ZHSKCYJHJBEUAO-FXPIJTFKSA-N 6-[2-[[(3ar,4r,6as)-4-(dibenzylamino)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CC[C@@H]5C4)N(CC=4C=CC=CC=4)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC ZHSKCYJHJBEUAO-FXPIJTFKSA-N 0.000 claims 1
- HIOZAHZHKCCWPK-RVSNTGDXSA-N 6-[2-[[(3ar,4r,6as)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CC[C@@H]5C4)N(C)C)N(C)C3=CC=2)=C1CC HIOZAHZHKCCWPK-RVSNTGDXSA-N 0.000 claims 1
- DREFIDLQNSJLMC-QGCDCVKKSA-N 6-[2-[[(3ar,4r,6as)-4-(dimethylamino)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CC[C@@H]5C4)N(C)C)N(C)C3=CC=2)=C1CC DREFIDLQNSJLMC-QGCDCVKKSA-N 0.000 claims 1
- VRYOARSOUYLXJZ-MDASCCDHSA-N 6-[2-[[(3ar,4r,6as)-4-amino-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@H](N)CC[C@@H]5C4)N(C)C3=CC=2)=C1CC VRYOARSOUYLXJZ-MDASCCDHSA-N 0.000 claims 1
- XZERUVJBFSAAAU-JWNONTMASA-N 6-[2-[[(3ar,4r,7as)-4-(dibenzylamino)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CCC[C@@H]5C4)N(CC=4C=CC=CC=4)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC XZERUVJBFSAAAU-JWNONTMASA-N 0.000 claims 1
- GCSBTXIUHJXGMP-HFRGRHLUSA-N 6-[2-[[(3ar,4r,7as)-4-(dimethylamino)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CCC[C@@H]5C4)N(C)C)N(C)C3=CC=2)=C1CC GCSBTXIUHJXGMP-HFRGRHLUSA-N 0.000 claims 1
- WZRMNXLMPHKJJP-JEVIFJNESA-N 6-[2-[[(3ar,4r,7as)-4-[benzyl(methyl)amino]-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@@H](CCC[C@@H]5C4)N(C)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC WZRMNXLMPHKJJP-JEVIFJNESA-N 0.000 claims 1
- VSUXUXXIIFORGR-UIAACRFSSA-N 6-[2-[[(3ar,4r,7as)-4-amino-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H]5[C@H](N)CCC[C@@H]5C4)N(C)C3=CC=2)=C1CC VSUXUXXIIFORGR-UIAACRFSSA-N 0.000 claims 1
- HNDLQVYSVZKJRX-INIZCTEOSA-N 6-[2-[[(3s)-3-aminopyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H](N)CC4)N(C)C3=CC=2)=C1CC HNDLQVYSVZKJRX-INIZCTEOSA-N 0.000 claims 1
- BBZHVPUGDNAPLH-AWEZNQCLSA-N 6-[2-[[(3s)-3-aminopyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C[C@@H](N)CC4)N(C)C3=CC=2)=C1CC BBZHVPUGDNAPLH-AWEZNQCLSA-N 0.000 claims 1
- ANMVZYBEMSOUOZ-UHFFFAOYSA-N 6-[2-[[2-(dimethylamino)ethyl-methylamino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CCN(C)C)N(C)C3=CC=2)=C1CC ANMVZYBEMSOUOZ-UHFFFAOYSA-N 0.000 claims 1
- WNJQOGGYLZEQKS-UHFFFAOYSA-N 6-[2-[[2-(dimethylamino)ethylamino]methyl]-1-methylindol-5-yl]-4-hydroxy-5-methyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C=1C=C2N(C)C(CNCCN(C)C)=CC2=CC=1C=1NC(=O)C(C(O)=O)=C(O)C=1C WNJQOGGYLZEQKS-UHFFFAOYSA-N 0.000 claims 1
- AWHKBYJFNHJWKC-UHFFFAOYSA-N 6-[2-[[2-(dimethylamino)ethylamino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CNCCN(C)C)N(C)C3=CC=2)=C1CC AWHKBYJFNHJWKC-UHFFFAOYSA-N 0.000 claims 1
- FEDFTQKWBBHXRA-UHFFFAOYSA-N 6-[2-[[2-[(dimethylamino)methyl]pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4C(CCC4)CN(C)C)N(C)C3=CC=2)=C1CC FEDFTQKWBBHXRA-UHFFFAOYSA-N 0.000 claims 1
- DIOGMRVBYSLHLJ-UHFFFAOYSA-N 6-[2-[[3-(2-aminopropan-2-yl)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)C(C)(C)N)N(C)C3=CC=2)=C1CC DIOGMRVBYSLHLJ-UHFFFAOYSA-N 0.000 claims 1
- DPEDZSMYBDMNOC-UHFFFAOYSA-N 6-[2-[[3-(dimethylamino)azetidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(C4)N(C)C)N(C)C3=CC=2)=C1CC DPEDZSMYBDMNOC-UHFFFAOYSA-N 0.000 claims 1
- HBHSVEODHZCUSX-UHFFFAOYSA-N 6-[2-[[3-(dimethylamino)piperidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CCC4)N(C)C)N(C)C3=CC=2)=C1CC HBHSVEODHZCUSX-UHFFFAOYSA-N 0.000 claims 1
- GBCPAIOGGQRVAR-UHFFFAOYSA-N 6-[2-[[3-(dimethylamino)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)N(C)C)N(C)C3=CC=2)=C1CC GBCPAIOGGQRVAR-UHFFFAOYSA-N 0.000 claims 1
- LJUIJIORLJJANH-UHFFFAOYSA-N 6-[2-[[3-(dimethylamino)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)N(C)C)N(C)C3=CC=2)=C1CC LJUIJIORLJJANH-UHFFFAOYSA-N 0.000 claims 1
- OPZWMTIHRDOSJC-UHFFFAOYSA-N 6-[2-[[3-(dimethylcarbamoyl)azetidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(C4)C(=O)N(C)C)N(C)C3=CC=2)=C1CC OPZWMTIHRDOSJC-UHFFFAOYSA-N 0.000 claims 1
- ZMGRAFAUPHGYHT-UHFFFAOYSA-N 6-[2-[[3-(dimethylcarbamoyl)pyrrolidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(CC4)C(=O)N(C)C)N(C)C3=CC=2)=C1CC ZMGRAFAUPHGYHT-UHFFFAOYSA-N 0.000 claims 1
- VHNFGMBYTXMAHS-UHFFFAOYSA-N 6-[2-[[3-[benzyl(methyl)amino]azetidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CC(C4)N(C)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC VHNFGMBYTXMAHS-UHFFFAOYSA-N 0.000 claims 1
- FHTIXWIQKIRUGU-UHFFFAOYSA-N 6-[2-[[4-(dimethylamino)piperidin-1-yl]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN4CCC(CC4)N(C)C)N(C)C3=CC=2)=C1CC FHTIXWIQKIRUGU-UHFFFAOYSA-N 0.000 claims 1
- WECKCNGVEIKAMS-UHFFFAOYSA-N 6-[2-[[acetyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C(C)=O)N(C)C3=CC=2)=C1CC WECKCNGVEIKAMS-UHFFFAOYSA-N 0.000 claims 1
- DSLKEADMZXGOKD-UHFFFAOYSA-N 6-[2-[[benzyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC DSLKEADMZXGOKD-UHFFFAOYSA-N 0.000 claims 1
- CWBFNGLUODNMHS-UHFFFAOYSA-N 6-[2-[[benzyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CC=4C=CC=CC=4)N(C)C3=CC=2)=C1CC CWBFNGLUODNMHS-UHFFFAOYSA-N 0.000 claims 1
- VWTQPINBQJWEOA-UHFFFAOYSA-N 6-[2-[[cyclopentyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C4CCCC4)N(C)C3=CC=2)=C1CC VWTQPINBQJWEOA-UHFFFAOYSA-N 0.000 claims 1
- OZNDFIMACVYJKL-UHFFFAOYSA-N 6-[2-[[cyclopropyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)C4CC4)N(C)C3=CC=2)=C1CC OZNDFIMACVYJKL-UHFFFAOYSA-N 0.000 claims 1
- LQEBBSRGVBGTOA-UHFFFAOYSA-N 6-[2-[[cyclopropylmethyl(methyl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(C)CC4CC4)N(C)C3=CC=2)=C1CC LQEBBSRGVBGTOA-UHFFFAOYSA-N 0.000 claims 1
- DTBZHBIIBJGXRW-UHFFFAOYSA-N 6-[2-[[cyclopropylmethyl(piperidin-3-yl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(CC4CC4)C4CNCCC4)N(C)C3=CC=2)=C1CC DTBZHBIIBJGXRW-UHFFFAOYSA-N 0.000 claims 1
- BAEBLTRQIVOIBV-UHFFFAOYSA-N 6-[2-[[cyclopropylmethyl(piperidin-4-yl)amino]methyl]-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C=C(CN(CC4CC4)C4CCNCC4)N(C)C3=CC=2)=C1CC BAEBLTRQIVOIBV-UHFFFAOYSA-N 0.000 claims 1
- AABQEBJCEOJVSN-UHFFFAOYSA-N 6-[3-(diethylaminomethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C2C(CN(CC)CC)=CN(C)C2=CC=C1C=1NC(=O)C(C(O)=O)=CC=1CC AABQEBJCEOJVSN-UHFFFAOYSA-N 0.000 claims 1
- NHYYQXCZHAXERH-UHFFFAOYSA-N 6-[3-(dimethylamino)-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4C(N(C)C)CCN4C3=CC=2)=C1CC NHYYQXCZHAXERH-UHFFFAOYSA-N 0.000 claims 1
- IMFWNUPKJZHVAA-UHFFFAOYSA-N 6-[3-[(dibenzylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C(CN(CC=4C=CC=CC=4)CC=4C=CC=CC=4)=CN(C)C3=CC=2)=C1CC IMFWNUPKJZHVAA-UHFFFAOYSA-N 0.000 claims 1
- CHOMNJJDXKTHBO-UHFFFAOYSA-N 6-[3-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C(CN(C)C)=CN(C)C3=CC=2)=C1CC CHOMNJJDXKTHBO-UHFFFAOYSA-N 0.000 claims 1
- HYCXPRVKVQNGIG-UHFFFAOYSA-N 6-[3-[3-(dimethylamino)pyrrolidin-1-yl]-2,3-dihydro-1h-pyrrolo[1,2-a]indol-6-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C=C3C=C4C(N5CC(CC5)N(C)C)CCN4C3=CC=2)=C1CC HYCXPRVKVQNGIG-UHFFFAOYSA-N 0.000 claims 1
- BNJUYKCCWDIKRN-UHFFFAOYSA-N 6-[3-cyano-2-(dimethylamino)-1-methylindol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C=2C=C3C(C#N)=C(N(C)C)N(C)C3=CC=2)=C1CC BNJUYKCCWDIKRN-UHFFFAOYSA-N 0.000 claims 1
- DPWPTFVWUZQIAV-UHFFFAOYSA-N 6-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-5-ethyl-4-hydroxy-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC1=C(C(O)=O)C(=O)NC(C2=NN3C=C(C)N=C(C3=C2)N(C)C)=C1CC DPWPTFVWUZQIAV-UHFFFAOYSA-N 0.000 claims 1
- QPOBJHYEQLZBAV-UHFFFAOYSA-N 6-[5-[(dimethylamino)methyl]-6-methylthieno[2,3-b]pyrrol-2-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(=O)NC(C=2SC=3N(C)C(CN(C)C)=CC=3C=2)=C1CC QPOBJHYEQLZBAV-UHFFFAOYSA-N 0.000 claims 1
- MDIIAQONWSQFEM-UHFFFAOYSA-N 6-[6-chloro-1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN4CCOCC4)=CC=3C=2)Cl)=C1CC MDIIAQONWSQFEM-UHFFFAOYSA-N 0.000 claims 1
- SRTZTVAIHWZOBX-UHFFFAOYSA-N 6-[6-chloro-2-(diethylaminomethyl)-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound ClC=1C=C2N(C)C(CN(CC)CC)=CC2=CC=1C=1NC(=O)C(C(O)=O)=CC=1CC SRTZTVAIHWZOBX-UHFFFAOYSA-N 0.000 claims 1
- BZWVIWDDQYGJLD-UHFFFAOYSA-N 6-[6-chloro-2-[(dimethylamino)methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)NC(C=2C(=CC=3N(C)C(CN(C)C)=CC=3C=2)Cl)=C1CC BZWVIWDDQYGJLD-UHFFFAOYSA-N 0.000 claims 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 claims 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 claims 1
- 108010001478 Bacitracin Proteins 0.000 claims 1
- HCYILUPQTNMOSW-UHFFFAOYSA-N C(C)C=1C=C(C(NC1C=1C=C2CCN(C2=CC1)C)=O)C(=O)O.C(C)C=1C(=C(C(NC1C=1C=CC2=C(OCCN2C)C1)=O)C(=O)O)O Chemical compound C(C)C=1C=C(C(NC1C=1C=C2CCN(C2=CC1)C)=O)C(=O)O.C(C)C=1C(=C(C(NC1C=1C=CC2=C(OCCN2C)C1)=O)C(=O)O)O HCYILUPQTNMOSW-UHFFFAOYSA-N 0.000 claims 1
- MYOLGMAFUYLEHE-UHFFFAOYSA-N C1(CC1)C=1C=C(C(NC1C=1C=C2C=CN(C2=CC1)C)=O)C(=O)O.OC1=C(C(NC(=C1C(C)C)C=1C=C2C=CN(C2=CC1)C)=O)C(=O)O Chemical compound C1(CC1)C=1C=C(C(NC1C=1C=C2C=CN(C2=CC1)C)=O)C(=O)O.OC1=C(C(NC(=C1C(C)C)C=1C=C2C=CN(C2=CC1)C)=O)C(=O)O MYOLGMAFUYLEHE-UHFFFAOYSA-N 0.000 claims 1
- PTQFREJJIJRILJ-INIZCTEOSA-N CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN3CCC[C@@H](C3)NC)cc2c1 Chemical compound CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN3CCC[C@@H](C3)NC)cc2c1 PTQFREJJIJRILJ-INIZCTEOSA-N 0.000 claims 1
- SPERDJAGBBUXCN-HNNXBMFYSA-N CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN3CCC[C@H](N)C3)cc2c1 Chemical compound CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN3CCC[C@H](N)C3)cc2c1 SPERDJAGBBUXCN-HNNXBMFYSA-N 0.000 claims 1
- IFZILXOFRSUSEL-JTQLQIEISA-N CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN[C@@H](C)C(F)(F)F)cc2c1 Chemical compound CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN[C@@H](C)C(F)(F)F)cc2c1 IFZILXOFRSUSEL-JTQLQIEISA-N 0.000 claims 1
- 108010065839 Capreomycin Proteins 0.000 claims 1
- ROOBDTWDYJWXKV-UHFFFAOYSA-N Cl.C(C)C=1C=C(C(NC1C=1C=CC=2N(C1)C=CN2)=O)C(=O)O.Cl Chemical compound Cl.C(C)C=1C=C(C(NC1C=1C=CC=2N(C1)C=CN2)=O)C(=O)O.Cl ROOBDTWDYJWXKV-UHFFFAOYSA-N 0.000 claims 1
- YJCRUDCCOQBPGG-XFULWGLBSA-N Cl.CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN[C@H](C)c3ccccc3)cc2c1 Chemical compound Cl.CCc1c(O)c(C(O)=O)c(=O)[nH]c1-c1ccc2n(C)c(CN[C@H](C)c3ccccc3)cc2c1 YJCRUDCCOQBPGG-XFULWGLBSA-N 0.000 claims 1
- JIAOVEQAUSJGFM-UHFFFAOYSA-N Cl.Cl.C(C)C=1C(=C(C(NC1C=1C=C2C=C(N(C2=CC1)C)CNCC1N(CCC1)CC)=O)C(=O)O)O Chemical compound Cl.Cl.C(C)C=1C(=C(C(NC1C=1C=C2C=C(N(C2=CC1)C)CNCC1N(CCC1)CC)=O)C(=O)O)O JIAOVEQAUSJGFM-UHFFFAOYSA-N 0.000 claims 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 claims 1
- 108010078777 Colistin Proteins 0.000 claims 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 claims 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 claims 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 claims 1
- 108010013198 Daptomycin Proteins 0.000 claims 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 claims 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 claims 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims 1
- 229930182566 Gentamicin Natural products 0.000 claims 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 claims 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims 1
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 claims 1
- 229930193140 Neomycin Natural products 0.000 claims 1
- 239000004100 Oxytetracycline Substances 0.000 claims 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 claims 1
- 229930195708 Penicillin V Natural products 0.000 claims 1
- 108010093965 Polymyxin B Proteins 0.000 claims 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 claims 1
- 108010053950 Teicoplanin Proteins 0.000 claims 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 claims 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 claims 1
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 claims 1
- 229960004821 amikacin Drugs 0.000 claims 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 claims 1
- 229960003022 amoxicillin Drugs 0.000 claims 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims 1
- 229960000723 ampicillin Drugs 0.000 claims 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims 1
- 229940003446 arsphenamine Drugs 0.000 claims 1
- VLAXZGHHBIJLAD-UHFFFAOYSA-N arsphenamine Chemical compound [Cl-].[Cl-].C1=C(O)C([NH3+])=CC([As]=[As]C=2C=C([NH3+])C(O)=CC=2)=C1 VLAXZGHHBIJLAD-UHFFFAOYSA-N 0.000 claims 1
- 229960004099 azithromycin Drugs 0.000 claims 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 1
- 229960003623 azlocillin Drugs 0.000 claims 1
- JTWOMNBEOCYFNV-NFFDBFGFSA-N azlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCNC1=O JTWOMNBEOCYFNV-NFFDBFGFSA-N 0.000 claims 1
- 229960003644 aztreonam Drugs 0.000 claims 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims 1
- 229960003071 bacitracin Drugs 0.000 claims 1
- 229930184125 bacitracin Natural products 0.000 claims 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims 1
- 229960004602 capreomycin Drugs 0.000 claims 1
- 229960003669 carbenicillin Drugs 0.000 claims 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 claims 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 claims 1
- 229960005361 cefaclor Drugs 0.000 claims 1
- 229960004841 cefadroxil Drugs 0.000 claims 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 claims 1
- 229960000603 cefalotin Drugs 0.000 claims 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 claims 1
- 229960003012 cefamandole Drugs 0.000 claims 1
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 claims 1
- 229960001139 cefazolin Drugs 0.000 claims 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 claims 1
- 229960003719 cefdinir Drugs 0.000 claims 1
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 claims 1
- 229960004069 cefditoren Drugs 0.000 claims 1
- KMIPKYQIOVAHOP-YLGJWRNMSA-N cefditoren Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1\C=C/C=1SC=NC=1C KMIPKYQIOVAHOP-YLGJWRNMSA-N 0.000 claims 1
- 229960002129 cefixime Drugs 0.000 claims 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 claims 1
- 229960004682 cefoperazone Drugs 0.000 claims 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 claims 1
- 229960004261 cefotaxime Drugs 0.000 claims 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 claims 1
- 229960002682 cefoxitin Drugs 0.000 claims 1
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 claims 1
- 229960005090 cefpodoxime Drugs 0.000 claims 1
- WYUSVOMTXWRGEK-HBWVYFAYSA-N cefpodoxime Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(O)=O)C(=O)C(=N/OC)\C1=CSC(N)=N1 WYUSVOMTXWRGEK-HBWVYFAYSA-N 0.000 claims 1
- 229960002580 cefprozil Drugs 0.000 claims 1
- 229960000484 ceftazidime Drugs 0.000 claims 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 claims 1
- 229960004086 ceftibuten Drugs 0.000 claims 1
- UNJFKXSSGBWRBZ-BJCIPQKHSA-N ceftibuten Chemical compound S1C(N)=NC(C(=C\CC(O)=O)\C(=O)N[C@@H]2C(N3C(=CCS[C@@H]32)C(O)=O)=O)=C1 UNJFKXSSGBWRBZ-BJCIPQKHSA-N 0.000 claims 1
- 229960001991 ceftizoxime Drugs 0.000 claims 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 claims 1
- 229960004755 ceftriaxone Drugs 0.000 claims 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 claims 1
- 229960001668 cefuroxime Drugs 0.000 claims 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 claims 1
- 229940106164 cephalexin Drugs 0.000 claims 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims 1
- DDTDNCYHLGRFBM-YZEKDTGTSA-N chembl2367892 Chemical compound CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@@H]([C@H]1C(N[C@@H](C2=CC(O)=CC(O[C@@H]3[C@H]([C@H](O)[C@H](O)[C@@H](CO)O3)O)=C2C=2C(O)=CC=C(C=2)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H]3C=4C=C(O)C=C(C=4)OC=4C(O)=CC=C(C=4)[C@@H](N)C(=O)N[C@H](CC=4C=C(Cl)C(O5)=CC=4)C(=O)N3)C(=O)N1)C(O)=O)=O)C(C=C1Cl)=CC=C1OC1=C(O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@H](CO)O3)NC(C)=O)C5=CC2=C1 DDTDNCYHLGRFBM-YZEKDTGTSA-N 0.000 claims 1
- MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 claims 1
- 229960005091 chloramphenicol Drugs 0.000 claims 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims 1
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 claims 1
- 229960004912 cilastatin Drugs 0.000 claims 1
- 229960002626 clarithromycin Drugs 0.000 claims 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 claims 1
- 229940090805 clavulanate Drugs 0.000 claims 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 claims 1
- 229960002227 clindamycin Drugs 0.000 claims 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims 1
- 229960004287 clofazimine Drugs 0.000 claims 1
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 claims 1
- 229960003326 cloxacillin Drugs 0.000 claims 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 claims 1
- 229960003346 colistin Drugs 0.000 claims 1
- 229960003077 cycloserine Drugs 0.000 claims 1
- 229960002615 dalfopristin Drugs 0.000 claims 1
- SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 claims 1
- 108700028430 dalfopristin Proteins 0.000 claims 1
- 229960000860 dapsone Drugs 0.000 claims 1
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 claims 1
- 229960005484 daptomycin Drugs 0.000 claims 1
- 229960001585 dicloxacillin Drugs 0.000 claims 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 claims 1
- 229960004100 dirithromycin Drugs 0.000 claims 1
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 claims 1
- 229960000895 doripenem Drugs 0.000 claims 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 claims 1
- 229960003722 doxycycline Drugs 0.000 claims 1
- 229960002549 enoxacin Drugs 0.000 claims 1
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 229960000285 ethambutol Drugs 0.000 claims 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims 1
- 229960002001 ethionamide Drugs 0.000 claims 1
- 229960004273 floxacillin Drugs 0.000 claims 1
- 229960000308 fosfomycin Drugs 0.000 claims 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 claims 1
- 229960001625 furazolidone Drugs 0.000 claims 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 claims 1
- 229960004675 fusidic acid Drugs 0.000 claims 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 claims 1
- 229960003923 gatifloxacin Drugs 0.000 claims 1
- 229960002518 gentamicin Drugs 0.000 claims 1
- 229960002182 imipenem Drugs 0.000 claims 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 claims 1
- 229960003350 isoniazid Drugs 0.000 claims 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims 1
- 229960000318 kanamycin Drugs 0.000 claims 1
- 229930027917 kanamycin Natural products 0.000 claims 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims 1
- 229930182823 kanamycin A Natural products 0.000 claims 1
- 229960005287 lincomycin Drugs 0.000 claims 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims 1
- 229960002422 lomefloxacin Drugs 0.000 claims 1
- ZEKZLJVOYLTDKK-UHFFFAOYSA-N lomefloxacin Chemical compound FC1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1 ZEKZLJVOYLTDKK-UHFFFAOYSA-N 0.000 claims 1
- 229960001977 loracarbef Drugs 0.000 claims 1
- JAPHQRWPEGVNBT-UTUOFQBUSA-N loracarbef Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)[NH3+])=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-N 0.000 claims 1
- 229960003640 mafenide Drugs 0.000 claims 1
- 229960002260 meropenem Drugs 0.000 claims 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 claims 1
- 229960000282 metronidazole Drugs 0.000 claims 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims 1
- 229960000198 mezlocillin Drugs 0.000 claims 1
- YPBATNHYBCGSSN-VWPFQQQWSA-N mezlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O YPBATNHYBCGSSN-VWPFQQQWSA-N 0.000 claims 1
- 229960004023 minocycline Drugs 0.000 claims 1
- 229960003128 mupirocin Drugs 0.000 claims 1
- 229930187697 mupirocin Natural products 0.000 claims 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 claims 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 claims 1
- 229960000515 nafcillin Drugs 0.000 claims 1
- GPXLMGHLHQJAGZ-JTDSTZFVSA-N nafcillin Chemical compound C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C(O)=O)=O)C(OCC)=CC=C21 GPXLMGHLHQJAGZ-JTDSTZFVSA-N 0.000 claims 1
- 229960004927 neomycin Drugs 0.000 claims 1
- 229960000808 netilmicin Drugs 0.000 claims 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 claims 1
- 229960000564 nitrofurantoin Drugs 0.000 claims 1
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims 1
- 229960001180 norfloxacin Drugs 0.000 claims 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims 1
- 229960001699 ofloxacin Drugs 0.000 claims 1
- 229960001019 oxacillin Drugs 0.000 claims 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 claims 1
- 229960000625 oxytetracycline Drugs 0.000 claims 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 1
- 235000019366 oxytetracycline Nutrition 0.000 claims 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims 1
- 229960001914 paromomycin Drugs 0.000 claims 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 claims 1
- 229940056360 penicillin g Drugs 0.000 claims 1
- 229940056367 penicillin v Drugs 0.000 claims 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 claims 1
- 229960002292 piperacillin Drugs 0.000 claims 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 claims 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- CSOMAHTTWTVBFL-OFBLZTNGSA-N platensimycin Chemical compound C([C@]1([C@@H]2[C@@H]3C[C@@H]4C[C@@]2(C=CC1=O)C[C@@]4(O3)C)C)CC(=O)NC1=C(O)C=CC(C(O)=O)=C1O CSOMAHTTWTVBFL-OFBLZTNGSA-N 0.000 claims 1
- CSOMAHTTWTVBFL-UHFFFAOYSA-N platensimycin Natural products O1C2(C)CC3(C=CC4=O)CC2CC1C3C4(C)CCC(=O)NC1=C(O)C=CC(C(O)=O)=C1O CSOMAHTTWTVBFL-UHFFFAOYSA-N 0.000 claims 1
- 229920000024 polymyxin B Polymers 0.000 claims 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 claims 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 claims 1
- 229960005266 polymyxin b Drugs 0.000 claims 1
- 229960005206 pyrazinamide Drugs 0.000 claims 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims 1
- 229960005442 quinupristin Drugs 0.000 claims 1
- WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 claims 1
- 108700028429 quinupristin Proteins 0.000 claims 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 1
- 229960000885 rifabutin Drugs 0.000 claims 1
- 229960002599 rifapentine Drugs 0.000 claims 1
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 claims 1
- 229960003040 rifaximin Drugs 0.000 claims 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 claims 1
- 229960005224 roxithromycin Drugs 0.000 claims 1
- 229960003600 silver sulfadiazine Drugs 0.000 claims 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 1
- 229960002930 sirolimus Drugs 0.000 claims 1
- 229960000268 spectinomycin Drugs 0.000 claims 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 claims 1
- 229960005322 streptomycin Drugs 0.000 claims 1
- 229960005256 sulbactam Drugs 0.000 claims 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 claims 1
- 229960002673 sulfacetamide Drugs 0.000 claims 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 claims 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 claims 1
- 229960004306 sulfadiazine Drugs 0.000 claims 1
- 229960000654 sulfafurazole Drugs 0.000 claims 1
- 229960005158 sulfamethizole Drugs 0.000 claims 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 claims 1
- 229960005404 sulfamethoxazole Drugs 0.000 claims 1
- 229960001940 sulfasalazine Drugs 0.000 claims 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 claims 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 claims 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 claims 1
- 229960003865 tazobactam Drugs 0.000 claims 1
- 229960001608 teicoplanin Drugs 0.000 claims 1
- ONUMZHGUFYIKPM-MXNFEBESSA-N telavancin Chemical compound O1[C@@H](C)[C@@H](O)[C@](NCCNCCCCCCCCCC)(C)C[C@@H]1O[C@H]1[C@H](OC=2C3=CC=4[C@H](C(N[C@H]5C(=O)N[C@H](C(N[C@@H](C6=CC(O)=C(CNCP(O)(O)=O)C(O)=C6C=6C(O)=CC=C5C=6)C(O)=O)=O)[C@H](O)C5=CC=C(C(=C5)Cl)O3)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C3=CC=C(C(=C3)Cl)OC=2C=4)O[C@H](CO)[C@@H](O)[C@@H]1O ONUMZHGUFYIKPM-MXNFEBESSA-N 0.000 claims 1
- 229960005240 telavancin Drugs 0.000 claims 1
- 108010089019 telavancin Proteins 0.000 claims 1
- 229960003250 telithromycin Drugs 0.000 claims 1
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 claims 1
- BVCKFLJARNKCSS-DWPRYXJFSA-N temocillin Chemical compound N([C@]1(OC)C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C=1C=CSC=1 BVCKFLJARNKCSS-DWPRYXJFSA-N 0.000 claims 1
- 229960001114 temocillin Drugs 0.000 claims 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 claims 1
- 229960003053 thiamphenicol Drugs 0.000 claims 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 claims 1
- 229960004659 ticarcillin Drugs 0.000 claims 1
- 229960005053 tinidazole Drugs 0.000 claims 1
- 229960000707 tobramycin Drugs 0.000 claims 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims 1
- 229960001082 trimethoprim Drugs 0.000 claims 1
- 229960005041 troleandomycin Drugs 0.000 claims 1
- LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 claims 1
- 244000000059 gram-positive pathogen Species 0.000 abstract description 6
- 244000000058 gram-negative pathogen Species 0.000 abstract description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 313
- 238000005160 1H NMR spectroscopy Methods 0.000 description 226
- 229910052757 nitrogen Inorganic materials 0.000 description 184
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 148
- 150000003254 radicals Chemical class 0.000 description 133
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 126
- 239000000203 mixture Substances 0.000 description 119
- 238000006243 chemical reaction Methods 0.000 description 104
- 239000000243 solution Substances 0.000 description 92
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 81
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 70
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 68
- 238000002360 preparation method Methods 0.000 description 68
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 66
- 239000002904 solvent Substances 0.000 description 60
- 239000011541 reaction mixture Substances 0.000 description 57
- 239000007787 solid Substances 0.000 description 49
- 229920006395 saturated elastomer Polymers 0.000 description 48
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 42
- 239000000047 product Substances 0.000 description 42
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 40
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 38
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 35
- 239000007832 Na2SO4 Substances 0.000 description 31
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 31
- 229910052938 sodium sulfate Inorganic materials 0.000 description 31
- 235000011152 sodium sulphate Nutrition 0.000 description 31
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 29
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 26
- 230000002829 reductive effect Effects 0.000 description 26
- 239000012043 crude product Substances 0.000 description 25
- 238000000746 purification Methods 0.000 description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- 239000012074 organic phase Substances 0.000 description 24
- 239000007858 starting material Substances 0.000 description 24
- 239000000725 suspension Substances 0.000 description 24
- 239000003960 organic solvent Substances 0.000 description 22
- 239000012071 phase Substances 0.000 description 22
- 108010054814 DNA Gyrase Proteins 0.000 description 21
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 21
- 238000004440 column chromatography Methods 0.000 description 21
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 21
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 20
- 235000017557 sodium bicarbonate Nutrition 0.000 description 20
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 20
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 19
- 238000011282 treatment Methods 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 18
- 150000002148 esters Chemical class 0.000 description 18
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- PCDHSSHKDZYLLI-UHFFFAOYSA-N butan-1-one Chemical compound CCC[C]=O PCDHSSHKDZYLLI-UHFFFAOYSA-N 0.000 description 17
- 238000003818 flash chromatography Methods 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 229910010066 TiC14 Inorganic materials 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 108091006629 SLC13A2 Proteins 0.000 description 15
- 229910052786 argon Inorganic materials 0.000 description 15
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 15
- 229940002612 prodrug Drugs 0.000 description 15
- 239000000651 prodrug Substances 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 14
- 101150055528 SPAM1 gene Proteins 0.000 description 13
- 229940088710 antibiotic agent Drugs 0.000 description 13
- 125000006239 protecting group Chemical group 0.000 description 13
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 12
- 108010041052 DNA Topoisomerase IV Proteins 0.000 description 12
- 229910004373 HOAc Inorganic materials 0.000 description 12
- ZPFKRQXYKULZKP-UHFFFAOYSA-N butylidene Chemical group [CH2+]CC[CH-] ZPFKRQXYKULZKP-UHFFFAOYSA-N 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 11
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 11
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Inorganic materials O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 11
- CDQXHVDVGLVACE-UHFFFAOYSA-N propan-2-amine Chemical compound [CH2]C(C)N CDQXHVDVGLVACE-UHFFFAOYSA-N 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000007792 addition Methods 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- 125000002950 monocyclic group Chemical group 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 238000010992 reflux Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 125000005843 halogen group Chemical group 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 150000002576 ketones Chemical class 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- 125000005605 benzo group Chemical group 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- RHFZTBSULNJWEI-UHFFFAOYSA-N dimethyl 2-(methoxymethylidene)propanedioate Chemical compound COC=C(C(=O)OC)C(=O)OC RHFZTBSULNJWEI-UHFFFAOYSA-N 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 150000002466 imines Chemical class 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000015320 potassium carbonate Nutrition 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 150000007660 quinolones Chemical class 0.000 description 7
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- ZEZJPIDPVXJEME-UHFFFAOYSA-N 2,4-Dihydroxypyridine Chemical class OC=1C=CNC(=O)C=1 ZEZJPIDPVXJEME-UHFFFAOYSA-N 0.000 description 5
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 5
- 102100034195 Thrombopoietin Human genes 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 5
- 125000001475 halogen functional group Chemical group 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- YDJXDYKQMRNUSA-UHFFFAOYSA-N tri(propan-2-yl)silane Chemical compound CC(C)[SiH](C(C)C)C(C)C YDJXDYKQMRNUSA-UHFFFAOYSA-N 0.000 description 5
- QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- SXXLKZCNJHJYFL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-5-ium-3-olate Chemical compound C1CNCC2=C1ONC2=O SXXLKZCNJHJYFL-UHFFFAOYSA-N 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
- HHTYEQWCHQEJNV-UHFFFAOYSA-N 4-bromo-2-iodoaniline Chemical compound NC1=CC=C(Br)C=C1I HHTYEQWCHQEJNV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 101710183280 Topoisomerase Proteins 0.000 description 4
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 4
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 4
- 239000012455 biphasic mixture Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000007859 condensation product Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 4
- 229940124307 fluoroquinolone Drugs 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- KHNDGDMDYRDYBR-UHFFFAOYSA-N n-methoxy-n-methylbutanamide Chemical compound CCCC(=O)N(C)OC KHNDGDMDYRDYBR-UHFFFAOYSA-N 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 235000011056 potassium acetate Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- BNOIMFITGLLJTH-UHFFFAOYSA-N trimethyl methanetricarboxylate Chemical compound COC(=O)C(C(=O)OC)C(=O)OC BNOIMFITGLLJTH-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 150000003738 xylenes Chemical class 0.000 description 4
- RVKHNGYQFXGYBH-UHFFFAOYSA-N (6-bromoimidazo[1,2-a]pyridin-2-yl)methoxy-tert-butyl-dimethylsilane Chemical compound C1=C(Br)C=CC2=NC(CO[Si](C)(C)C(C)(C)C)=CN21 RVKHNGYQFXGYBH-UHFFFAOYSA-N 0.000 description 3
- MPOYBFYHRQBZPM-UHFFFAOYSA-N 3h-pyridin-4-one Chemical class O=C1CC=NC=C1 MPOYBFYHRQBZPM-UHFFFAOYSA-N 0.000 description 3
- KPBXZZMKTKHMEX-UHFFFAOYSA-N 4-benzamido-3-hydroxybenzoic acid Chemical compound OC1=CC(C(=O)O)=CC=C1NC(=O)C1=CC=CC=C1 KPBXZZMKTKHMEX-UHFFFAOYSA-N 0.000 description 3
- 108020000946 Bacterial DNA Proteins 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000013066 combination product Substances 0.000 description 3
- 229940127555 combination product Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical class C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- OVTSHYPXQRTQHI-UHFFFAOYSA-N methyl n-(4-bromo-2-iodophenyl)carbamate Chemical compound COC(=O)NC1=CC=C(Br)C=C1I OVTSHYPXQRTQHI-UHFFFAOYSA-N 0.000 description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- 230000036470 plasma concentration Effects 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 3
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 3
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- SQHSJJGGWYIFCD-UHFFFAOYSA-N (e)-1-diazonio-1-dimethoxyphosphorylprop-1-en-2-olate Chemical compound COP(=O)(OC)C(\[N+]#N)=C(\C)[O-] SQHSJJGGWYIFCD-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- NLAPTLUVVJSIHL-UHFFFAOYSA-N 1-(4-amino-3-hydroxyphenyl)butan-1-one Chemical compound CCCC(=O)C1=CC=C(N)C(O)=C1 NLAPTLUVVJSIHL-UHFFFAOYSA-N 0.000 description 2
- XPXZIZIGEKZVMQ-UHFFFAOYSA-N 1-methyl-3,4-dihydro-2h-quinoline-6-carbaldehyde Chemical compound O=CC1=CC=C2N(C)CCCC2=C1 XPXZIZIGEKZVMQ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CYQINFGJHKYVSX-UHFFFAOYSA-N 1-o-benzyl 4-o-tert-butyl 2-ethynylpiperazine-1,4-dicarboxylate Chemical compound C#CC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OCC1=CC=CC=C1 CYQINFGJHKYVSX-UHFFFAOYSA-N 0.000 description 2
- KNEAWSKMVBSXNO-UHFFFAOYSA-N 1-o-benzyl 4-o-tert-butyl 2-formylpiperazine-1,4-dicarboxylate Chemical compound O=CC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OCC1=CC=CC=C1 KNEAWSKMVBSXNO-UHFFFAOYSA-N 0.000 description 2
- QPFGPTWKWVMPBW-UHFFFAOYSA-N 2,4-bis(phenylmethoxy)pyridine Chemical class C=1C=CC=CC=1COC(C=1)=CC=NC=1OCC1=CC=CC=C1 QPFGPTWKWVMPBW-UHFFFAOYSA-N 0.000 description 2
- ONUGXXHJSIJCRG-UHFFFAOYSA-N 2-(5-bromo-1h-indol-2-yl)ethoxy-tert-butyl-dimethylsilane Chemical compound BrC1=CC=C2NC(CCO[Si](C)(C)C(C)(C)C)=CC2=C1 ONUGXXHJSIJCRG-UHFFFAOYSA-N 0.000 description 2
- AZDIQNDLLGCIHK-UHFFFAOYSA-N 2-(dimethylamino)-1,3-benzoxazole-6-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2OC(N(C)C)=NC2=C1 AZDIQNDLLGCIHK-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- IWTFOFMTUOBLHG-UHFFFAOYSA-N 2-methoxypyridine Chemical class COC1=CC=CC=N1 IWTFOFMTUOBLHG-UHFFFAOYSA-N 0.000 description 2
- ICSRYAQXSYGQSJ-UHFFFAOYSA-N 2-phenyl-1,3-benzoxazole-6-carboxylic acid Chemical compound O1C2=CC(C(=O)O)=CC=C2N=C1C1=CC=CC=C1 ICSRYAQXSYGQSJ-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- VCPQSQMJPCIGSB-UHFFFAOYSA-N 5-chloro-6-ethyl-3-methoxy-1,4-oxazin-2-one Chemical compound CCC=1OC(=O)C(OC)=NC=1Cl VCPQSQMJPCIGSB-UHFFFAOYSA-N 0.000 description 2
- FCOVETUMFYMUDU-UHFFFAOYSA-N 6-chloro-5-ethyl-2-methoxypyridine-3-carboxylic acid Chemical compound CCC1=CC(C(O)=O)=C(OC)N=C1Cl FCOVETUMFYMUDU-UHFFFAOYSA-N 0.000 description 2
- HFDLDPJYCIEXJP-UHFFFAOYSA-N 6-methoxyquinoline Chemical group N1=CC=CC2=CC(OC)=CC=C21 HFDLDPJYCIEXJP-UHFFFAOYSA-N 0.000 description 2
- CECJUHKZSOSOJJ-SNVBAGLBSA-N 7-[(3r)-3-(2-aminopropan-2-yl)pyrrolidin-1-yl]-9-cyclopropyl-6-fluoro-8-methoxy-[1,2]thiazolo[5,4-b]quinoline-3,4-dione Chemical compound FC1=CC(C(C=2C(=O)NSC=2N2C3CC3)=O)=C2C(OC)=C1N1CC[C@@H](C(C)(C)N)C1 CECJUHKZSOSOJJ-SNVBAGLBSA-N 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 235000006491 Acacia senegal Nutrition 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- YVBSECQAHGIWNF-UHFFFAOYSA-N N-methyl-1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2N(C)CCCC2=C1 YVBSECQAHGIWNF-UHFFFAOYSA-N 0.000 description 2
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 229910021120 PdC12 Inorganic materials 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- QXHKKCITURTUFC-UHFFFAOYSA-N [1,2]thiazolo[3,4-h]quinoline 8-oxide Chemical class C1=CN=C2C3=CS(=O)N=C3C=CC2=C1 QXHKKCITURTUFC-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000012084 conversion product Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 125000006001 difluoroethyl group Chemical group 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- CISNVHUZRHMKGA-UHFFFAOYSA-N ethyl 2-bromo-6-methylthieno[2,3-b]pyrrole-5-carboxylate Chemical compound C1=C(Br)SC2=C1C=C(C(=O)OCC)N2C CISNVHUZRHMKGA-UHFFFAOYSA-N 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 101150013736 gyrB gene Proteins 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- QYKREGWWUVWBLF-UHFFFAOYSA-N methyl 2-(dimethylamino)-1,3-benzoxazole-6-carboxylate Chemical compound COC(=O)C1=CC=C2N=C(N(C)C)OC2=C1 QYKREGWWUVWBLF-UHFFFAOYSA-N 0.000 description 2
- OAJQIGHFNLIIJM-UHFFFAOYSA-N methyl 6-chloro-5-ethyl-2-methoxypyridine-3-carboxylate Chemical compound CCC1=CC(C(=O)OC)=C(OC)N=C1Cl OAJQIGHFNLIIJM-UHFFFAOYSA-N 0.000 description 2
- JODBXKXOFVISMZ-UHFFFAOYSA-N methyl n-[4-bromo-2-(4-hydroxybut-1-ynyl)phenyl]carbamate Chemical compound COC(=O)NC1=CC=C(Br)C=C1C#CCCO JODBXKXOFVISMZ-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- WOHXVUMWLCJPAE-UHFFFAOYSA-N n-methoxy-n-methyl-2-phenyl-1,3-benzoxazole-6-carboxamide Chemical compound O1C2=CC(C(=O)N(C)OC)=CC=C2N=C1C1=CC=CC=C1 WOHXVUMWLCJPAE-UHFFFAOYSA-N 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 239000003865 nucleic acid synthesis inhibitor Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- LBKJNHPKYFYCLL-UHFFFAOYSA-N potassium;trimethyl(oxido)silane Chemical compound [K+].C[Si](C)(C)[O-] LBKJNHPKYFYCLL-UHFFFAOYSA-N 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 150000008515 quinazolinediones Chemical class 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000008137 solubility enhancer Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- XFQNWPYGEGCIMF-HCUGAJCMSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].[Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 XFQNWPYGEGCIMF-HCUGAJCMSA-N 0.000 description 1
- UEBTVOYBDFQPOU-UHFFFAOYSA-N (2-bromo-6-methylthieno[2,3-b]pyrrol-5-yl)methanol Chemical compound C1=C(Br)SC2=C1C=C(CO)N2C UEBTVOYBDFQPOU-UHFFFAOYSA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- PAORVUMOXXAMPL-SECBINFHSA-N (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride Chemical compound CO[C@](C(Cl)=O)(C(F)(F)F)C1=CC=CC=C1 PAORVUMOXXAMPL-SECBINFHSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- SLYZVDLXWHZNCR-UHFFFAOYSA-N (6-bromo-2,3-dihydro-1h-pyrrolo[1,2-a]indol-3-yl)oxy-tert-butyl-dimethylsilane Chemical compound BrC1=CC=C2N3CCC(O[Si](C)(C)C(C)(C)C)C3=CC2=C1 SLYZVDLXWHZNCR-UHFFFAOYSA-N 0.000 description 1
- SDEYJBQEUWYUMO-UHFFFAOYSA-N (6-bromoimidazo[1,2-a]pyridin-2-yl)methanol Chemical compound C1=C(Br)C=CC2=NC(CO)=CN21 SDEYJBQEUWYUMO-UHFFFAOYSA-N 0.000 description 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 125000006013 1,1-difluoroethoxy group Chemical group 0.000 description 1
- 125000006002 1,1-difluoroethyl group Chemical group 0.000 description 1
- ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical compound NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 description 1
- FAVOZNLUAZFOSI-UHFFFAOYSA-N 1-(1-methyl-2,3-dihydroindol-5-yl)butan-1-one Chemical compound CCCC(=O)C1=CC=C2N(C)CCC2=C1 FAVOZNLUAZFOSI-UHFFFAOYSA-N 0.000 description 1
- FXIBSNXLGNQIOO-UHFFFAOYSA-N 1-(1-methyl-3,4-dihydro-2h-quinolin-6-yl)butan-1-one Chemical compound CN1CCCC2=CC(C(=O)CCC)=CC=C21 FXIBSNXLGNQIOO-UHFFFAOYSA-N 0.000 description 1
- IFKHSONBZGUZMY-UHFFFAOYSA-N 1-(2-methyl-1,3-benzoxazol-6-yl)butan-1-one Chemical compound CCCC(=O)C1=CC=C2N=C(C)OC2=C1 IFKHSONBZGUZMY-UHFFFAOYSA-N 0.000 description 1
- YRJOXVKIKWEMRA-UHFFFAOYSA-N 1-(2-phenyl-1,3-benzoxazol-6-yl)butan-1-one Chemical compound O1C2=CC(C(=O)CCC)=CC=C2N=C1C1=CC=CC=C1 YRJOXVKIKWEMRA-UHFFFAOYSA-N 0.000 description 1
- FXBJSLLNXHPKBJ-UHFFFAOYSA-N 1-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)butan-1-one Chemical compound C1CCCC2=C1N(C)C1=CC=C(C(=O)CCC)C=C12 FXBJSLLNXHPKBJ-UHFFFAOYSA-N 0.000 description 1
- ZROKLRWAYWLDOZ-UHFFFAOYSA-N 1-[2-(dimethylamino)-1,3-benzoxazol-6-yl]butan-1-one Chemical compound CCCC(=O)C1=CC=C2N=C(N(C)C)OC2=C1 ZROKLRWAYWLDOZ-UHFFFAOYSA-N 0.000 description 1
- IPCRFGFTKUNSFR-UHFFFAOYSA-N 1-[2-[[tert-butyl(dimethyl)silyl]oxymethyl]-1-methylindol-5-yl]-n-[(2,4-dimethoxyphenyl)methyl]butan-1-imine Chemical compound C=1C=C2N(C)C(CO[Si](C)(C)C(C)(C)C)=CC2=CC=1C(CCC)=NCC1=CC=C(OC)C=C1OC IPCRFGFTKUNSFR-UHFFFAOYSA-N 0.000 description 1
- BEWVEIHXOINSOA-UHFFFAOYSA-N 1-[2-[[tert-butyl(dimethyl)silyl]oxymethyl]-1-methylindol-5-yl]butan-1-one Chemical compound CCCC(=O)C1=CC=C2N(C)C(CO[Si](C)(C)C(C)(C)C)=CC2=C1 BEWVEIHXOINSOA-UHFFFAOYSA-N 0.000 description 1
- MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical class CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- CUDKGPNSGMKSPF-UHFFFAOYSA-N 1-ethylindole-5-carbonitrile Chemical compound N#CC1=CC=C2N(CC)C=CC2=C1 CUDKGPNSGMKSPF-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FIRXFHJQGIIJDB-UHFFFAOYSA-N 1-methyl-2,3-dihydroindole Chemical compound C1=CC=C2N(C)CCC2=C1 FIRXFHJQGIIJDB-UHFFFAOYSA-N 0.000 description 1
- OZQGVTARHLDSTI-UHFFFAOYSA-N 1-methyl-2,3-dihydroindole-5-carbaldehyde Chemical compound O=CC1=CC=C2N(C)CCC2=C1 OZQGVTARHLDSTI-UHFFFAOYSA-N 0.000 description 1
- PDELHKUNNNEBDR-UHFFFAOYSA-N 1-methyl-2,3-dihydroindole-5-carbonitrile Chemical compound N#CC1=CC=C2N(C)CCC2=C1 PDELHKUNNNEBDR-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ZUEOHWIJNVOIRG-UHFFFAOYSA-N 1-methyl-3,4-dihydro-2h-quinoline-6-carbonitrile Chemical compound N#CC1=CC=C2N(C)CCCC2=C1 ZUEOHWIJNVOIRG-UHFFFAOYSA-N 0.000 description 1
- BLRHMMGNCXNXJL-UHFFFAOYSA-N 1-methylindole Chemical compound C1=CC=C2N(C)C=CC2=C1 BLRHMMGNCXNXJL-UHFFFAOYSA-N 0.000 description 1
- UINOMZOGOKYFHD-UHFFFAOYSA-N 1-o-benzyl 4-o-tert-butyl 2-(hydroxymethyl)piperazine-1,4-dicarboxylate Chemical compound OCC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OCC1=CC=CC=C1 UINOMZOGOKYFHD-UHFFFAOYSA-N 0.000 description 1
- OWVBGCAHKKYQAI-UHFFFAOYSA-N 1-o-benzyl 4-o-tert-butyl 2-[2-(2-amino-5-bromophenyl)ethynyl]piperazine-1,4-dicarboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCN(C(=O)OCC=2C=CC=CC=2)C1C#CC1=CC(Br)=CC=C1N OWVBGCAHKKYQAI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JSOYHSSJZOFZOC-UHFFFAOYSA-N 1-quinolin-6-ylbutan-1-one Chemical compound N1=CC=CC2=CC(C(=O)CCC)=CC=C21 JSOYHSSJZOFZOC-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- YHYLDEVWYOFIJK-UHFFFAOYSA-N 1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC=CC2=C1 YHYLDEVWYOFIJK-UHFFFAOYSA-N 0.000 description 1
- SDQJTWBNWQABLE-UHFFFAOYSA-N 1h-quinazoline-2,4-dione Chemical group C1=CC=C2C(=O)NC(=O)NC2=C1 SDQJTWBNWQABLE-UHFFFAOYSA-N 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- NYOWYNSNCXRVNQ-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-indazole Chemical class C1=CCC2CNNC2=C1 NYOWYNSNCXRVNQ-UHFFFAOYSA-N 0.000 description 1
- CSDFHCDNAZPVKH-UHFFFAOYSA-N 2,3,3a,7a-tetrahydro-1h-indazole Chemical compound C1=CC=CC2CNNC21 CSDFHCDNAZPVKH-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- GSVRAAFPAIWJLO-UHFFFAOYSA-N 2-chloro-4,6-bis(phenylmethoxy)pyridine Chemical class C=1C(OCC=2C=CC=CC=2)=NC(Cl)=CC=1OCC1=CC=CC=C1 GSVRAAFPAIWJLO-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- KHWGRLRCZSYJNT-UHFFFAOYSA-N 2-oxo-3h-pyridine-3-carboxylic acid Chemical class OC(=O)C1C=CC=NC1=O KHWGRLRCZSYJNT-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QWZHDKGQKYEBKK-UHFFFAOYSA-N 3-aminochromen-2-one Chemical compound C1=CC=C2OC(=O)C(N)=CC2=C1 QWZHDKGQKYEBKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- QRMRRLXXFHXMBC-UHFFFAOYSA-N 3-methyl-1,3-benzoxazol-2-one Chemical compound C1=CC=C2OC(=O)N(C)C2=C1 QRMRRLXXFHXMBC-UHFFFAOYSA-N 0.000 description 1
- NFPYJDZQOKCYIE-UHFFFAOYSA-N 4-amino-3-hydroxybenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1O NFPYJDZQOKCYIE-UHFFFAOYSA-N 0.000 description 1
- YJRQBOOMJGYUPI-UHFFFAOYSA-N 4-methyl-2,3-dihydro-1,4-benzoxazine Chemical compound C1=CC=C2N(C)CCOC2=C1 YJRQBOOMJGYUPI-UHFFFAOYSA-N 0.000 description 1
- DSGZFICETCIKPL-UHFFFAOYSA-N 5-bromo-1-(1,3-dioxolan-2-ylmethyl)indole Chemical compound C1=CC2=CC(Br)=CC=C2N1CC1OCCO1 DSGZFICETCIKPL-UHFFFAOYSA-N 0.000 description 1
- KLQGRTUSJNRAHN-UHFFFAOYSA-N 5-bromo-1-[2-(oxan-2-yloxy)ethyl]indole Chemical compound C1=CC2=CC(Br)=CC=C2N1CCOC1CCCCO1 KLQGRTUSJNRAHN-UHFFFAOYSA-N 0.000 description 1
- DBUWKSQHDKNTDN-UHFFFAOYSA-N 6-bromo-1,2-dihydropyrrolo[1,2-a]indol-3-one Chemical compound BrC1=CC=C2N(CCC3=O)C3=CC2=C1 DBUWKSQHDKNTDN-UHFFFAOYSA-N 0.000 description 1
- SGYJGCFMAGWFCF-UHFFFAOYSA-N 6-bromo-2,3,4,9-tetrahydro-1h-carbazole Chemical compound C1CCCC2=C1NC1=CC=C(Br)C=C12 SGYJGCFMAGWFCF-UHFFFAOYSA-N 0.000 description 1
- YWIPKRNFMHVJMY-UHFFFAOYSA-N 6-bromo-9-methyl-1,2,3,4-tetrahydrocarbazole Chemical compound C12=CC(Br)=CC=C2N(C)C2=C1CCCC2 YWIPKRNFMHVJMY-UHFFFAOYSA-N 0.000 description 1
- CXRXKDSDRWLKTK-UHFFFAOYSA-N 6-bromo-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=C(Br)C=CC2=NC=NN21 CXRXKDSDRWLKTK-UHFFFAOYSA-N 0.000 description 1
- WRZHCJAMRKTKNK-UHFFFAOYSA-N 6-butanoyl-3h-1,3-benzoxazol-2-one Chemical compound CCCC(=O)C1=CC=C2NC(=O)OC2=C1 WRZHCJAMRKTKNK-UHFFFAOYSA-N 0.000 description 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 description 1
- ZLICIITZJTYKAQ-DIOULYMOSA-N 7-[(3r)-3-(1-aminocyclopropyl)pyrrolidin-1-yl]-1-[(1r,2s)-2-fluorocyclopropyl]-8-methoxy-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(N2C[C@@H](CC2)C2(N)CC2)C=CC(C(C(C(O)=O)=C2)=O)=C1N2[C@@H]1C[C@@H]1F ZLICIITZJTYKAQ-DIOULYMOSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000034356 Aframomum angustifolium Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- QOROSXYTKAMFAC-CQSZACIVSA-N CC(C)(C)OC(=O)N1CCC[C@@H]1C#Cc1cc(Br)ccc1N Chemical compound CC(C)(C)OC(=O)N1CCC[C@@H]1C#Cc1cc(Br)ccc1N QOROSXYTKAMFAC-CQSZACIVSA-N 0.000 description 1
- GPEVBUBKXPYVOA-UHFFFAOYSA-N CN1CCCC2=CC(=CC=C12)C=NO.CN1CCCC2=CC(=CC=C12)C#N Chemical compound CN1CCCC2=CC(=CC=C12)C=NO.CN1CCCC2=CC(=CC=C12)C#N GPEVBUBKXPYVOA-UHFFFAOYSA-N 0.000 description 1
- DVHQXWQTNCDJSE-UHFFFAOYSA-N CON(C)C(=O)c1ccc2nc(oc2c1)N(C)C Chemical compound CON(C)C(=O)c1ccc2nc(oc2c1)N(C)C DVHQXWQTNCDJSE-UHFFFAOYSA-N 0.000 description 1
- DRMPIEBNFMNRPZ-UHFFFAOYSA-N COS1(=O)CC(C2=NC=CC=C2C=C2)=C2N1N1CCCC1 Chemical class COS1(=O)CC(C2=NC=CC=C2C=C2)=C2N1N1CCCC1 DRMPIEBNFMNRPZ-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000685938 Escherichia coli NDM-1 Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 229910004039 HBF4 Inorganic materials 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229910013470 LiC1 Inorganic materials 0.000 description 1
- 108010004718 Lipoglycopeptides Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 102100020846 Methylosome subunit pICln Human genes 0.000 description 1
- 101710201208 Methylosome subunit pICln Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100189356 Mus musculus Papolb gene Proteins 0.000 description 1
- ZKGNPQKYVKXMGJ-UHFFFAOYSA-N N,N-dimethylacetamide Chemical compound CN(C)C(C)=O.CN(C)C(C)=O ZKGNPQKYVKXMGJ-UHFFFAOYSA-N 0.000 description 1
- FCNSGGAWZFMXFQ-RPERETBRSA-N NC1=C(C=C(C=C1)Br)C#C[C@@H]1N(CCC1)C(=O)OC(C)(C)C.NC1=C(C=C(C=C1)Br)C#C[C@@H]1N(CCC1)C(=O)OC(C)(C)C Chemical compound NC1=C(C=C(C=C1)Br)C#C[C@@H]1N(CCC1)C(=O)OC(C)(C)C.NC1=C(C=C(C=C1)Br)C#C[C@@H]1N(CCC1)C(=O)OC(C)(C)C FCNSGGAWZFMXFQ-RPERETBRSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- HGCLPWSOABWDJR-UHFFFAOYSA-N OCCC#Cc1cc(Br)ccc1NC(O)=O Chemical compound OCCC#Cc1cc(Br)ccc1NC(O)=O HGCLPWSOABWDJR-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108700006385 OmpF Proteins 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- VMKVDAAFMQKZJS-LFIBNONCSA-N acorafloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCC\C(=C(/F)CN)C1 VMKVDAAFMQKZJS-LFIBNONCSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 150000005840 aryl radicals Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000005872 benzooxazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 150000005347 biaryls Chemical class 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- DYDCPNMLZGFQTM-UHFFFAOYSA-N delafloxacin Chemical compound C1=C(F)C(N)=NC(N2C3=C(Cl)C(N4CC(O)C4)=C(F)C=C3C(=O)C(C(O)=O)=C2)=C1F DYDCPNMLZGFQTM-UHFFFAOYSA-N 0.000 description 1
- 229950006412 delafloxacin Drugs 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical class CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 description 1
- NRNFKRFWZQQDMD-UHFFFAOYSA-M dichloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=C(Cl)Cl NRNFKRFWZQQDMD-UHFFFAOYSA-M 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000006006 difluoroethoxy group Chemical group 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004460 dihydrobenzooxazinyl group Chemical group O1N(CCC2=C1C=CC=C2)* 0.000 description 1
- 125000004459 dihydrobenzooxazolyl group Chemical group O1C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004582 dihydrobenzothienyl group Chemical group S1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005047 dihydroimidazolyl group Chemical group N1(CNC=C1)* 0.000 description 1
- 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005051 dihydropyrazinyl group Chemical group N1(CC=NC=C1)* 0.000 description 1
- 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 125000005053 dihydropyrimidinyl group Chemical group N1(CN=CC=C1)* 0.000 description 1
- 125000004609 dihydroquinazolinyl group Chemical group N1(CN=CC2=CC=CC=C12)* 0.000 description 1
- 125000005044 dihydroquinolinyl group Chemical group N1(CC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005057 dihydrothienyl group Chemical group S1C(CC=C1)* 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- JMRYOSQOYJBDOI-UHFFFAOYSA-N dilithium;di(propan-2-yl)azanide Chemical compound [Li+].CC(C)[N-]C(C)C.CC(C)N([Li])C(C)C JMRYOSQOYJBDOI-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- QKGQDKWRQNGYHN-UHFFFAOYSA-N ethyl 2-bromo-6h-thieno[2,3-b]pyrrole-5-carboxylate Chemical compound C1=C(Br)SC2=C1C=C(C(=O)OCC)N2 QKGQDKWRQNGYHN-UHFFFAOYSA-N 0.000 description 1
- RLEUBLNVHZTFOH-UHFFFAOYSA-N ethyl 5-bromo-1-methylindole-2-carboxylate Chemical compound BrC1=CC=C2N(C)C(C(=O)OCC)=CC2=C1 RLEUBLNVHZTFOH-UHFFFAOYSA-N 0.000 description 1
- LWRLKENDQISGEU-UHFFFAOYSA-N ethyl 5-bromo-1h-indole-2-carboxylate Chemical compound BrC1=CC=C2NC(C(=O)OCC)=CC2=C1 LWRLKENDQISGEU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000005256 gram-negative cell Anatomy 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 101150070420 gyrA gene Proteins 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical compound O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-M isonicotinate Chemical compound [O-]C(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-M 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000005969 isothiazolinyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 125000003971 isoxazolinyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000004715 keto acids Chemical group 0.000 description 1
- 239000003835 ketolide antibiotic agent Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- ULKSWZAXQDJMJT-UHFFFAOYSA-M magnesium;2,2,6,6-tetramethylpiperidin-1-ide;chloride Chemical compound [Cl-].CC1(C)CCCC(C)(C)N1[Mg+] ULKSWZAXQDJMJT-UHFFFAOYSA-M 0.000 description 1
- RYEXTBOQKFUPOE-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].CC[CH2-] RYEXTBOQKFUPOE-UHFFFAOYSA-M 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 241001515942 marmosets Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- BCVXHSPFUWZLGQ-UHFFFAOYSA-N mecn acetonitrile Chemical compound CC#N.CC#N BCVXHSPFUWZLGQ-UHFFFAOYSA-N 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 1
- OCZXDVNSNDITBS-UHFFFAOYSA-N methyl 4-amino-3-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(N)C(O)=C1 OCZXDVNSNDITBS-UHFFFAOYSA-N 0.000 description 1
- ZKUUVVYMPUDTGJ-UHFFFAOYSA-N methyl 5-hydroxy-4-methoxy-2-nitrobenzoate Chemical compound COC(=O)C1=CC(O)=C(OC)C=C1[N+]([O-])=O ZKUUVVYMPUDTGJ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- IMAKHNTVDGLIRY-UHFFFAOYSA-N methyl prop-2-ynoate Chemical compound COC(=O)C#C IMAKHNTVDGLIRY-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 238000011294 monotherapeutic Methods 0.000 description 1
- IHFZUIBTENSHSH-UHFFFAOYSA-N n,n-dimethoxy-1-phenylmethanamine Chemical compound CON(OC)CC1=CC=CC=C1 IHFZUIBTENSHSH-UHFFFAOYSA-N 0.000 description 1
- VIJUZNJJLALGNJ-UHFFFAOYSA-N n,n-dimethylbutanamide Chemical compound CCCC(=O)N(C)C VIJUZNJJLALGNJ-UHFFFAOYSA-N 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- SPDFKTMBEJBOEM-UHFFFAOYSA-N n-[(1-methyl-2,3-dihydroindol-5-yl)methylidene]hydroxylamine Chemical compound ON=CC1=CC=C2N(C)CCC2=C1 SPDFKTMBEJBOEM-UHFFFAOYSA-N 0.000 description 1
- UGHMYKBKLDOGHC-UHFFFAOYSA-N n-[(1-methyl-3,4-dihydro-2h-quinolin-6-yl)methylidene]hydroxylamine Chemical compound ON=CC1=CC=C2N(C)CCCC2=C1 UGHMYKBKLDOGHC-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- QWFSFNKADLAQGG-UHFFFAOYSA-N n-methoxy-n-methylquinoline-6-carboxamide Chemical compound N1=CC=CC2=CC(C(=O)N(C)OC)=CC=C21 QWFSFNKADLAQGG-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- AOVFBEWTWUNVKS-UHFFFAOYSA-N n-tert-butyl-1-(1-methyl-2,3-dihydroindol-5-yl)butan-1-imine Chemical compound CCCC(=NC(C)(C)C)C1=CC=C2N(C)CCC2=C1 AOVFBEWTWUNVKS-UHFFFAOYSA-N 0.000 description 1
- LNKPKRRJKMQIOD-UHFFFAOYSA-N n-tert-butyl-1-(2-phenyl-1,3-benzoxazol-6-yl)butan-1-imine Chemical compound O1C2=CC(C(=NC(C)(C)C)CCC)=CC=C2N=C1C1=CC=CC=C1 LNKPKRRJKMQIOD-UHFFFAOYSA-N 0.000 description 1
- UWPXQSZGTSRSBX-UHFFFAOYSA-N n-tert-butyl-1-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]butan-1-imine Chemical compound C1=CC2=CC(C(=NC(C)(C)C)CCC)=CC=C2N1CC1OCCO1 UWPXQSZGTSRSBX-UHFFFAOYSA-N 0.000 description 1
- XGWPGXFTAJYXIQ-UHFFFAOYSA-N n-tert-butyl-1-quinolin-6-ylbutan-1-imine Chemical compound N1=CC=CC2=CC(C(=NC(C)(C)C)CCC)=CC=C21 XGWPGXFTAJYXIQ-UHFFFAOYSA-N 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- VWBWQOUWDOULQN-UHFFFAOYSA-N nmp n-methylpyrrolidone Chemical compound CN1CCCC1=O.CN1CCCC1=O VWBWQOUWDOULQN-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000005963 oxadiazolidinyl group Chemical group 0.000 description 1
- 125000005882 oxadiazolinyl group Chemical group 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- YWWARDMVSMPOLR-UHFFFAOYSA-M oxolane;tetrabutylazanium;fluoride Chemical compound [F-].C1CCOC1.CCCC[N+](CCCC)(CCCC)CCCC YWWARDMVSMPOLR-UHFFFAOYSA-M 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 101150012629 parE gene Proteins 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000008180 pharmaceutical surfactant Substances 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 101150107339 rpsN gene Proteins 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- MKFYNQAKTJFISL-VIFPVBQESA-N tert-butyl (2r)-2-ethynylpyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC[C@@H]1C#C MKFYNQAKTJFISL-VIFPVBQESA-N 0.000 description 1
- QOROSXYTKAMFAC-AWEZNQCLSA-N tert-butyl (2s)-2-[2-(2-amino-5-bromophenyl)ethynyl]pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1C#CC1=CC(Br)=CC=C1N QOROSXYTKAMFAC-AWEZNQCLSA-N 0.000 description 1
- IIIHAJOCDZZZTK-UHFFFAOYSA-N tert-butyl 3-[2-(2-amino-5-bromophenyl)ethynyl]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1C#CC1=CC(Br)=CC=C1N IIIHAJOCDZZZTK-UHFFFAOYSA-N 0.000 description 1
- KTDGOUSDBBFBRO-UHFFFAOYSA-N tert-butyl 3-ethynylpyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C#C)C1 KTDGOUSDBBFBRO-UHFFFAOYSA-N 0.000 description 1
- XHBZGCJELJTZFQ-UHFFFAOYSA-N tert-butyl 8-bromo-3,4-dihydro-1h-pyrazino[1,2-a]indole-2-carboxylate Chemical compound BrC1=CC=C2N3CCN(C(=O)OC(C)(C)C)CC3=CC2=C1 XHBZGCJELJTZFQ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 125000005887 tetrahydrobenzofuranyl group Chemical group 0.000 description 1
- 125000005886 tetrahydrobenzothienyl group Chemical group 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000005888 tetrahydroindolyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000005304 thiadiazolidinyl group Chemical group 0.000 description 1
- 125000005305 thiadiazolinyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 description 1
- 238000003354 tissue distribution assay Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- ZGYICYBLPGRURT-UHFFFAOYSA-N tri(propan-2-yl)silicon Chemical compound CC(C)[Si](C(C)C)C(C)C ZGYICYBLPGRURT-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000005310 triazolidinyl group Chemical group N1(NNCC1)* 0.000 description 1
- 125000005881 triazolinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- MHNHYTDAOYJUEZ-UHFFFAOYSA-N triphenylphosphane Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 MHNHYTDAOYJUEZ-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical class OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161528599P | 2011-08-29 | 2011-08-29 | |
| US61/528,599 | 2011-08-29 | ||
| PCT/US2012/052922 WO2013033258A1 (en) | 2011-08-29 | 2012-08-29 | Antibacterial compounds and methods for use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2846663A1 true CA2846663A1 (en) | 2013-03-07 |
Family
ID=47756844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2846663A Abandoned CA2846663A1 (en) | 2011-08-29 | 2012-08-29 | Antibacterial compounds and methods for use |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9409905B2 (https=) |
| EP (1) | EP2750504A4 (https=) |
| JP (1) | JP2014525453A (https=) |
| KR (1) | KR20140097118A (https=) |
| CN (1) | CN103889224B (https=) |
| AU (1) | AU2012301953C1 (https=) |
| BR (1) | BR112014004515A2 (https=) |
| CA (1) | CA2846663A1 (https=) |
| CL (1) | CL2014000469A1 (https=) |
| HK (1) | HK1199693A1 (https=) |
| IL (1) | IL231060A (https=) |
| MX (1) | MX2014002298A (https=) |
| WO (1) | WO2013033258A1 (https=) |
| ZA (1) | ZA201402248B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1199792A1 (en) * | 2011-08-29 | 2015-07-24 | Ptc Therapeutics, Inc. | Antibacterial compounds and methods for use |
| WO2014139388A1 (en) * | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2014157382A1 (ja) * | 2013-03-29 | 2014-10-02 | 味の素株式会社 | スフィンゴシンキナーゼ阻害剤 |
| WO2016039939A1 (en) * | 2014-09-09 | 2016-03-17 | Ptc Therapeutics, Inc. | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds |
| WO2016039937A1 (en) * | 2014-09-09 | 2016-03-17 | Ptc Therapeutics, Inc. | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds |
| WO2016109706A1 (en) * | 2014-12-31 | 2016-07-07 | Ptc Therapeutics, Inc. | Fused polycyclic 2-pyridinone antibacterial compounds |
| WO2018200571A1 (en) | 2017-04-25 | 2018-11-01 | Arbutus Biopharma Corporation | Substituted 2,3-dihydro-1h-indene analogs and methods using same |
| JP7153645B2 (ja) * | 2017-06-08 | 2022-10-14 | 三井化学アグロ株式会社 | ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤 |
| CN107325080B (zh) * | 2017-08-30 | 2020-05-12 | 延边大学 | 含三嗪或氨基胍结构的咔唑类衍生物的制备方法及其抗菌应用 |
| GB2571950A (en) | 2018-03-13 | 2019-09-18 | Azad Pharma Ag | New polymorph and new path to synthesize tafamidis |
| US12083118B2 (en) | 2018-03-29 | 2024-09-10 | Arbutus Biopharma Corporation | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same |
| CN108659091B (zh) * | 2018-05-24 | 2020-07-03 | 烟台大学 | 夫西地酸衍生物及其合成制备方法和应用 |
| JP2021534246A (ja) * | 2018-08-16 | 2021-12-09 | レクレオ ファーマシューティカルス アイエヌシー | 1,3,4,9−テトラヒドロ−2h−ピリド[3,4−b]インドール誘導体化合物及びその使用 |
| CN109329290A (zh) * | 2018-10-11 | 2019-02-15 | 四川省兰月科技有限公司 | 防治猕猴桃、柑橘黄化病的农药组合物 |
| CN109485601B (zh) * | 2018-12-23 | 2020-06-30 | 沧州普瑞东方科技有限公司 | 2,6-二卤吡啶-3-羧酸的合成方法 |
| CN111521706A (zh) * | 2020-05-11 | 2020-08-11 | 苏州必宜生物科技有限公司 | 一种快速检测血浆中头孢克肟浓度的方法 |
| AU2022424463A1 (en) * | 2021-12-28 | 2024-07-18 | Adeka Corporation | Aryl tetrahydropyridine derivative or salt thereof, pest control agent containing same, and method for use thereof |
| CN115960031B (zh) * | 2023-01-06 | 2024-09-10 | 暨南大学 | 一种四氢异吲哚酮类化合物及其制备方法和应用 |
| CN119569650A (zh) * | 2024-12-05 | 2025-03-07 | 凯美克(上海)医药科技有限公司 | 一种7-溴-2-氯喹啉-4-醇的合成方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3703582A (en) | 1970-04-20 | 1972-11-21 | Merck & Co Inc | Aryl pyridine carboxylic acids in the treatment of inflammation |
| US3948903A (en) * | 1972-12-15 | 1976-04-06 | Parke, Davis & Company | Substituted N-(1,2-dihydro-2-oxonicotinyl)-cephalexins and -cephaloglycins |
| US3954734A (en) | 1974-01-21 | 1976-05-04 | Parke, Davis & Company | Novel antibacterial amide compounds and process means for producing the same |
| JPS5643288A (en) | 1979-09-18 | 1981-04-21 | Meiji Seika Kaisha Ltd | Cephalosporin derivative and its preparation |
| JPS5651488A (en) | 1979-10-02 | 1981-05-09 | Meiji Seika Kaisha Ltd | Penicillin derivative and its preparation |
| DE3338846A1 (de) * | 1982-10-29 | 1984-05-03 | Toyama Chemical Co. Ltd., Tokyo | Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben |
| EP0308020A3 (en) | 1987-09-18 | 1990-12-05 | Merck & Co. Inc. | 5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof |
| GB8809481D0 (en) | 1988-04-21 | 1988-05-25 | Smith Kline French Lab | Chemical compounds |
| IE911704A1 (en) * | 1990-05-21 | 1991-12-04 | Smith Kline French Lab | Chemical compounds |
| DE19639817A1 (de) * | 1996-09-27 | 1998-04-02 | Hoechst Ag | Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen |
| CN1231161A (zh) | 1998-07-07 | 1999-10-13 | 邱泽国 | 全自动多功能超声波洗碗机 |
| EP1343763A1 (en) | 2000-11-20 | 2003-09-17 | Bristol-Myers Squibb Company | Pyrodone derivatives as ap2 inhibitors |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| ATE448784T1 (de) * | 2002-02-14 | 2009-12-15 | Pharmacia Corp | Substituierte pyridinone als modulatoren für p38 map kinase |
| CN101531631B (zh) | 2002-02-14 | 2011-09-28 | 法玛西雅公司 | 作为p38map激酶调节剂的取代吡啶酮类 |
| CL2004002050A1 (es) | 2003-08-13 | 2005-06-03 | Pharmacia Corp Sa Organizada B | Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros. |
| TWI360539B (en) | 2004-10-28 | 2012-03-21 | Shionogi & Co | 3-carbamoyl-2-pyridone derivatives |
| CN101171247A (zh) * | 2005-03-04 | 2008-04-30 | 阿斯利康(瑞典)有限公司 | 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物 |
| WO2006117762A2 (en) | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Antimicrobial agents |
| CA2713128C (en) | 2008-01-25 | 2016-04-05 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| HK1199792A1 (en) * | 2011-08-29 | 2015-07-24 | Ptc Therapeutics, Inc. | Antibacterial compounds and methods for use |
| CA2846655A1 (en) * | 2011-08-29 | 2013-03-07 | Arthur Branstrom | Antibacterial compounds and methods for use |
-
2012
- 2012-08-29 AU AU2012301953A patent/AU2012301953C1/en not_active Ceased
- 2012-08-29 KR KR1020147008210A patent/KR20140097118A/ko not_active Withdrawn
- 2012-08-29 CA CA2846663A patent/CA2846663A1/en not_active Abandoned
- 2012-08-29 JP JP2014528562A patent/JP2014525453A/ja not_active Ceased
- 2012-08-29 WO PCT/US2012/052922 patent/WO2013033258A1/en not_active Ceased
- 2012-08-29 BR BR112014004515A patent/BR112014004515A2/pt not_active IP Right Cessation
- 2012-08-29 US US14/241,506 patent/US9409905B2/en not_active Expired - Fee Related
- 2012-08-29 HK HK15100101.9A patent/HK1199693A1/xx unknown
- 2012-08-29 CN CN201280051906.5A patent/CN103889224B/zh not_active Expired - Fee Related
- 2012-08-29 MX MX2014002298A patent/MX2014002298A/es unknown
- 2012-08-29 EP EP12828218.3A patent/EP2750504A4/en not_active Withdrawn
-
2014
- 2014-02-20 IL IL231060A patent/IL231060A/en not_active IP Right Cessation
- 2014-02-26 CL CL2014000469A patent/CL2014000469A1/es unknown
- 2014-03-26 ZA ZA2014/02248A patent/ZA201402248B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9409905B2 (en) | 2016-08-09 |
| NZ623063A (en) | 2016-04-29 |
| AU2012301953C1 (en) | 2016-11-03 |
| EP2750504A4 (en) | 2015-03-11 |
| CN103889224A (zh) | 2014-06-25 |
| ZA201402248B (en) | 2016-06-29 |
| CL2014000469A1 (es) | 2014-11-14 |
| EP2750504A1 (en) | 2014-07-09 |
| CN103889224B (zh) | 2017-05-24 |
| JP2014525453A (ja) | 2014-09-29 |
| WO2013033258A1 (en) | 2013-03-07 |
| AU2012301953A1 (en) | 2014-03-13 |
| BR112014004515A2 (pt) | 2017-03-28 |
| IL231060A0 (en) | 2014-03-31 |
| US20150038437A1 (en) | 2015-02-05 |
| IL231060A (en) | 2017-01-31 |
| MX2014002298A (es) | 2014-07-22 |
| KR20140097118A (ko) | 2014-08-06 |
| HK1199693A1 (en) | 2015-07-17 |
| AU2012301953B2 (en) | 2016-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9409905B2 (en) | Antibacterial compounds and methods for use | |
| US9650395B2 (en) | Antibacterial compounds and methods for use | |
| EP2750678B1 (en) | Antibacterial compounds and methods for use | |
| CA2929316C (en) | Pyrazole for the treatment autoimmune disorders | |
| CA2902781C (en) | Novel pyrazole derivative | |
| CA3172498A1 (en) | Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use | |
| WO2016025933A2 (en) | Substituted polycyclic antibacterial compounds | |
| CN112513021B (zh) | RORγ拮抗剂及其在药物中的应用 | |
| WO2016025932A1 (en) | Substituted polycyclic antibacterial compounds | |
| WO2016039939A1 (en) | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds | |
| WO2016039937A1 (en) | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds | |
| NZ623063B2 (en) | Antibacterial compounds and methods for use | |
| WO2016039936A2 (en) | Monocyclic substituted 2-pyridinone antibacterial compounds | |
| NZ623056B2 (en) | Antibacterial compounds and methods for use | |
| HK1199706B (en) | Antibacterial compounds and methods for use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20180829 |